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Abstract
INTRODUCTION: Ionising radiation can induce DNA damage,  in  the  form of 
DNA double strand breaks (DSBs), which the affected cell may or may not be able 
to  repair.  Micronuclei  are  indicators  of  cytogenetic  damage,  which  result  from 
aneugenic  (spontaneous  loss  of  chromosomes)  or  clastogenic  (chromosomal 
fragments)  events.  The  micronuclei  may be  centromere-positive  (CM+MN) for 
aneugenic events or centromere-negative (CM–MN) for clastogenic events. A pan-
centromeric  marker  would  help  differentiate  between  CM+MN  and  CM–MN, 
especially important among exposures to very low doses of ionising radiation. 
METHODOLOGY:  Micronucleus  assays  were  performed  on  blood  samples 
collected  from  healthy  donors  and  HIV+  donors.  The  blood  samples  were 
irradiated at various doses of ionising radiation. Two methods were used to create a 
pan-centromeric  probe.  First,  the  p82H  plasmid,  which  contains  centromere 
specific α repetitive human DNA sequences, was used. Second, human centromeric 
sequences were amplified using polymerase chain reaction (PCR). In both cases, 
the pan-centromeric probe was labelled and hybridised using fluorescent  in situ 
hybridisation (FISH) to micronucleus slide preparations from healthy and HIV+ 
donors. The slides were scored manually and on an automated system, MetaFer®.
RESULTS: The p82H probe did not hybridise to any centromeres when FISH was 
performed,  while  the  synthetic  probe  made  by  means  of  PCR  bound  to  the 
centromeres of all chromosomes. Henceforth, all experiments were performed with 
the  synthetic  pan-centromeric  probe.  A dose  response  study was  performed on 
micronucleus slides from healthy donors, from which significant differences in the 
number  of  micronuclei  and  the  percentage  of  centromere-negative  micronuclei 
could be seen between doses. The HIV study involving HIV+ donors and HIV– 
controls did not yield any significant differences between the two groups. 
DISCUSSION & CONCLUSION:  Combining  the  micronucleus  assay with  the 
pan-centromeric probe greatly improves its  sensitivity.  The dose response study 
corroborated previous work performed by Vral et al (1997). Contrary to what was 
expected  and  published  (Baeyens  et  al,  2010),  no  significant  differences  were 
observed between HIV+ and HIV- individuals. Issues, improvements and possible 
future work are discussed. 
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CHAPTER ONE:  INTRODUCTION
1.1 Radiobiology
Radiobiology is the study of what happens after an organism absorbs energy 
from ionising radiation, what it does to compensate for the effects of this 
energy and what types of damage are caused.
1.1.1 Ionising Radiation
Radiation  is  defined  as  energy that  is  travelling  in  waves  or  high-speed 
particles.  Ionising  radiation  has  enough  energy  to  separate  at  least  one 
electron from a molecule. The various types of ionising radiation can be 
divided into high- and low-LET (linear energy transfer) radiation. The LET 
of the radiation determines how effective a dose of radiation is in generating 
residual (unrepaired) cellular damage. High-LET radiation like neutrons and 
alpha-particles  induce  much  more  cellular  damage  per  unit  of  radiation 
energy absorbed compared with that from low-LET sources of radiation e.g. 
gamma rays and X-rays. Ionising radiation can be produced by radioactive 
decay, nuclear fission, nuclear fusion, and particle accelerators (Dianiak et 
al,  2003;  Tubiana  et  al,  1990).  Gamma  and  X-radiation  have  different 
origins  –  gamma  radiation  originates  from processes  inside  the  nucleus, 
while X-radiation from processes outside the nucleus, such as a change in 
electron structure of an atom, and is mostly electronically produced.
Ionising radiation causes damage in living tissues by producing ionisations 
upon interaction with a cell. These ionisations can disrupt molecules, such 
as  DNA,  directly  and/or  indirectly  by  producing  highly  reactive  free 
radicals,  which will  lead to DNA damage.  Ionising radiation can have a 
variety  of  biological  effects,  such  as  damaging  the  integrity  of  the  cell 
leading to cell death, disrupting protein molecules, causing lesions in sugars, 
as  well  as  inducing  DNA damage,  which  can  result  in  changes  in  gene 
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expression,  gene  mutations,  chromosomal  aberrations,  and  genomic 
instability. A sufficient number of genetic alterations, may eventually lead to 
the development of cancer. Because ionising radiation is very effective in 
generating cellular damage and killing cells, it is used in the treatment of 
cancer.  Ionising  radiation  is  used  in  many disciplines  from medicine  to 
industrial  applications.  The  dangers  associated  with  radiation  exposure 
depend on  the  strength  of  radiation,  the  type  of  radiation  and length  of 
exposure.  The  damage  caused  by radiation  is  divided  into  early  effects, 
which occur shortly after exposure, but usually only with high doses i.e. 
acute  exposure,  and late  effects,  which happen years after  exposure,  and 
even at low doses i.e. chronic exposure (exposure to low doses may occur 
frequently over a long period) (Dianiak et al, 2003; Tubiana et al, 1990). 
1.1.2 DNA damage and repair
Ionising  radiation  can  have  various  effects  on  DNA and  chromosomes. 
These include 1) changes to or loss of a base, 2) single strand breaks (SSB), 
where a lesion occurs in one strand of a DNA molecule,  3) double-strand 
breaks (DSB), in which breaks occur in both strands of a DNA molecule, 4) 
cross-linking within a DNA molecule (intrastrand) or between other DNA 
molecules (DNA interstrand) or other molecules (DNA-protein) and 5) the 
destruction of sugars. These different types of damage can occur separately, 
as simple lesions, which are mostly efficiently repaired, or they can occur 
together resulting in complex lesions, which are more difficult to repair, and 
are often repaired incorrectly or not at  all.  The un- or mis-repaired DSB 
often results in the formation of chromosomal aberrations (Tubiana et al, 
1990). 
The  cell  has  various  distinct  repair  mechanisms,  which  are  activated  in 
response to DNA damage along with cell cycle checkpoints. The type of 
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DNA damage determines what repair mechanism is to be used. There are 
five main DNA damage repair pathways in mammalian cells: 
1) MisMatch  Repair  (MMR),  which  proofreads  newly-synthesised 
DNA strands  and  fixes  any  mismatched  bases  that  occur  during 
replication and/or recombination,
2) Base Excision Repair (BER), which repairs small lesions, such as 
damaged bases, throughout the cell cycle,
3) Nucleotide Excision Repair  (NER), which removes bulky  lesions 
that distort the helix, and then DNA polymerase fills in the resulting 
gap, 
4) Homologous Recombination (HR), which is responsible, along with 
5) Non-Homologous End-Joining (NHEJ) for the repair of DNA DSBs 
(Christmann et al, 2003; Hoeijmakers, 2001).
The DSB is the most genotoxic DNA lesion induced by ionising radiation. A 
single DSB that remains unrepaired is capable of effecting apoptosis, or can 
induce  other  genotoxic  effects,  such  as  chromosomal  breaks,  loss  and 
translocations (Christmann et al, 2003). The two main repair pathways of 
DNA DSBs, HR and NHEJ, are presented in Figure 1. The determination of 
which pathway is used to repair the DSB is dependent upon the phase of the 
cell cycle during which the DSB is detected in the cell. HR occurs mainly in 
late S and G2 phases, where homologous chromosomes are available, whilst 
NHEJ occurs in the G0/G1 phases of the cell  cycle.  In human cells,  the 
majority  of  the  DSBs  are  repaired  by  means  of  NHEJ,  with  only 
approximately  10%  being  repaired  by  means  of  HR  (Christmann  et  al, 
2003).
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Figure  1:  Representation  of  non-homologous  end-joining  (NHEJ)  and 
homologous recombination (Khanna et al, 2001; modified)
HR is considered to be error-free as it involves copying information from 
undamaged chromosomes or chromatids to repair double strand breaks. It 
takes  place  more  commonly in  simple  eukaryotes.  The  RAD52 epistasis 
group, including genes such as  RAD51,  RAD52 and  RAD54, mediates the 
HR process (Kanaar et al., 1998; Pfeiffer et al., 2004). During HR, a DSB is 
cut  from the  5'-end  to  the  3'-end  by  the  MRE11-RAD50-NBS1  protein 
4
complex. A complex made up of RAD52 proteins attaches itself to the 3' 
single stranded DNA, to protect it from exonucleolytic digestion. It has also 
been suggested that as RAD52 competes with the Ku protein to bind the 
DNA, it may influence the decision toward HR versus NHEJ. The RAD52 
proteins interact with RAD51 and RPA proteins, which will effect RAD51's 
DNA exchange activity. Strand exchange events occur when the damaged 
strand interacts with homologous regions on an undamaged chromosome, 
displacing a strand from that chromosome; this is catalysed by the RAD51 
protein. The RPA protein binds to the displaced strand thereby stabilising 
the pairing of the damaged and undamaged strands (Figure 1). A RAD51 
nucleoprotein  filament  assembles,  aided  by  the  RAD51B,  RAD51C, 
RAD51D, XRCRR2 and XRCRR3 proteins. HR then resolves, according to 
the Holliday model  (Christmann et al, 2003).
NHEJ  is  the  main  mechanism  by  which  irradiation-induced  DSBs  are 
removed in higher eukaryotes and it is regarded as being error-prone. NHEJ 
joins  two  ends  of  DSB  without  the  requirement  of  sequence  homology 
between the DNA ends. A heterodimer of Ku70 and Ku80 proteins bind to 
the  DSB  and  protects  the  DNA from  exonuclease  digestion.  The  Ku 
heterodimer  interacts  with  DNA-PKCS and  XRCC7 proteins  to  form the 
active DNA-PK holoenzyme. Thereafter, the MRE11-RAD50-NBS1 protein 
complex,  which  has  exonuclease,  endonuclease  and  helicase  activity, 
processes  DSBs by removing the  3'-flaps  while  the  protein,  FEN1 (flap 
endonuclease  1),  removes  the  5'-flaps.  The  protein,  Artemis,  forms  a 
complex with DNA-PKCS  and aids in processing the 3'- and 5'-ends (Ma et 
al,  2002).  The  XRCC4  protein  (a  target  of  DNA-PKCS)  forms  a  stable 
complex with DNA ligase IV, which binds the ends of DNA molecules and 
joins them together (Christmann et al, 2003).
There are a variety of proteins involved in recognising and signalling DNA 
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damage, and checkpoint control.  The phosphatidylinositol-3-kinases, such 
as ATM (Ataxia telangiectasia mutated), ATR (Ataxia telangiectasia related) 
and DNA-PKCS,  all recognise DNA breaks.  ATM and ATR bind onto the 
ends of damaged DNA and activate their own kinase activity. Changes in 
chromatin structure, resulting from exposure to ionising radiation, may play 
a role in activating ATM. The DNA-damage repair proteins have also been 
found  to  be  associated  with  surveillance  complexes  such  as  BASC 
(BRCA1-associated  surveillence  complex).  BASC  has  been  found  to  be 
associated  with  the  following  proteins,  BRCA1,  MSH2,  MSH6,  MLH1, 
ATM, BLM, and the MRE11-RAD50-NBS1 complex. The proteins, CHK1, 
CHK2  and  p53,  which  are  phosphorylated  by  ATM  and/or  ATR  are 
important  in  signalling  cell  cycle  arrest  at  G1/S  and  G2/M,  as  well  as 
apoptosis; they also enhance DNA repair (Christmann et al, 2003).
It has been assumed that DNA repair responses occur equally efficiently at 
high and low doses of ionising radiation. However, Rothkamm and Lobrich 
(2003) found this was not the case in their study. Rather, they observed that 
at  low doses,  DSBs remain unrepaired,  and if  the cells  were allowed to 
proliferate damaged cells are eliminated rather than being repaired. 
1.1.3 Chromosomal aberrations
DNA DSBs are one of the major effects of ionising radiation. Chromosomal 
aberrations form when the DNA DSB is not repaired or mis-repaired. There 
are  different  types  of   chromosome  aberrations  that  can  be  induced  by 
ionising radiation, such as (Figure 2):  
• acentric fragments, 
• dicentrics, 
• rings, 
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• translocations, 
• inversions and 
• deletions. 
Chromatid aberrations may also occur and they include breaks or exchanges 
(Figure 2). 
These  chromosomal  aberrations  can  be  stable  or  unstable.  Stable 
aberrations,  such  as  translocations  and  inversions,  occur  because  of 
symmetrical exchanges, and no genetic information is lost. Translocations 
can occur  on the same chromosome,  or between different  chromosomes. 
Stable  aberrations  can result  in  altered gene expression,  up-regulation of 
oncogenes  and down-regulation  of  tumour  suppressor  genes,  which  may 
ultimately advance the development of cancer (Baeyens,  2005). Unstable 
aberrations, resulting from asymmetric exchanges, are those where genetic 
information is lost. One example is when acentric fragments, chromosomal 
fragments lacking a centromere, are expelled from the nucleus because they 
are unable to attach to the spindle apparatus during cell division. Nuclear 
membranes can form around these fragments to form micronuclei,  which 
appear in the cytoplasm. As the nuclei lose this genetic information, the cell 
may stall in the cell cycle, and cell  death may occur. Other examples of 
unstable aberrations include dicentric chromosomes and ring chromosomes 
(Tubiana et al, 1990).  
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Figure  2:  Different  types  of  chromosome  and  chromatid  aberrations 
(Tubiana et al., 1990)
1.1.4 Biodosimetry
Radiation protection legislation sets effective dose limits for occupational 
yearly exposure, which includes the sum of internal and external exposure, 
but not natural background radiation or medical exposure. The dose limits 
are  often based on a  linear-no-threshold (LNT) model,  which assumes a 
worst  case  scenario;  this  often  leads  to  an  overestimation  of  the  risks 
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involved.
When  using  ionising  radiation,  the  following  principles  should  be 
considered: 
A) Justification Principle
The benefits of using ionising radiation must outweigh the risks involved, 
and  its  use  must  be  justified  when  comparing  it  to  the  use  of  other 
techniques.
B) Optimisation
Exposure must be kept as low as reasonably achievable (ALARA).
C) Principle of Individual Dose Limits
Dose limits must never be surpassed. For every act involving radiation a 
study should  be  done to  determine  the  lowest  possible  dose and risk  to 
determine a working level of radiation exposure.
1.1.5 Biomonitoring
Human Bio Monitoring was defined by Zielhuis (1984) as “ a systematic 
continuous or repetitive activity for collection of pollutants, metabolites or 
specific non-adverse biological effect parameters for immediate application, 
with the objective to assess exposure and health risk to exposed subjects, 
comparing the data observed with the reference level and – if necessary – 
leading to corrective actions.”
Basically, biomonitoring refers to the use of scientific techniques to assess 
exposures to natural or synthetic agents or chemicals. Biomonitoring can be 
performed  because  chemicals  and  agents  leave  evidence  in  exposed 
individuals such as chemicals or their metabolites, or cellular components 
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that  have  been  affected  by exposure,  such  as  ionising  radiation.  Tissues 
and/or  fluids  from  exposed  individuals  are  analysed  to  detect  these 
“markers”. Biomonitoring is categorised into 1) dose monitoring (defined as 
the  determination  of  hazardous  substances  or  their  metabolites  in  body 
fluids), 2) biochemical effect monitoring ( the quantification of the reaction 
products  of  reactive  substances  with  biological  molecules  e.g.  DNA or 
protein adducts) and 3) biological effect monitoring ( the measurement of 
early biological effects caused by agents e.g micronuclei) (Angerer et al, 
2007).
Angerer et al (2007) suggest several factors that should be fulfilled to ensure 
that  the biomonitoring is  suitable and dependable.  Firstly,  an appropriate 
biological  matrix  is  required.  The  biological  matrix  needs  to  be  easily 
obtainable  from the patient,  without  causing harm to that  person,  but  in 
adequate  amounts  to  perform  the  tests  required.  Blood  and  urine  are 
excellent  examples  fulfilling  these  criteria.  Secondly,  suitable  parameters 
that reflect internal exposure, biochemical or biological effects are needed. 
Each  biomarker  has  individual  characteristics  regarding  sensitivity  and 
specificity,  and  its  usefulness  can  be  influenced  by  the  selection  of 
biological specimens (Au, 2007). Micronuclei as well as other chromosomal 
aberrations are examples of early biological effect biomarkers. Thirdly, the 
analytical methods used need to be suitable for what is being looked for and 
on  what  specimen.  The  analytical  methods  also  need  to  be  reliable  and 
reproducible.  Finally,  reference  and  limit  values  are  needed.  Reference 
values are statistical descriptions of the background exposure of a certain 
population group; limit  values refer to the limits below which and above 
which harmless effects or harmful effects occur respectively (Angerer et al, 
2007).
 
Dose response studies can be performed to establish reference values as well 
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as to determine “safe” and “hazardous” limit values. Dose response studies 
trace how an effect on an organism, caused by a stressor (such as ionising 
radiation) changes with respect to differing doses or levels of exposure after 
a certain time period. It is important to establish reference values in order to 
interpret results, and to establish individual reference values since there is 
individual variation regarding the expression of biomarkers – some are less 
susceptible while others are more susceptible to radiation (Au, 2007). 
Biomonitoring is important for the health protection of workers who may 
possibly be exposed to chemicals or agents in the workplace. It is used to 
help check  that health practices are followed and that individuals are kept 
safe from possible exposures. Biomonitoring is used to assess exposures and 
to determine the potential health effects or consequent risks. It can also aid 
in risk management and policy-making as well as in the identification of 
groups  of  workers  that  are  at  higher  risk (Angerer  et  al,  2007).  Another 
application of biomonitoring involves shedding light on human metabolic 
response to radiation in vivo without experimental exposure (Angerer et al, 
2007).
iThemba LABS, in collaboration with the Radiation Regulatory Authorities 
in  South Africa (the Directorate  Radiation Control  of  the Department  of 
Health  and  the  National  Nuclear  Regulator)  are  currently  conducting  a 
project to biomonitor radiation workers, which can be done by analysing 
chromosomal damage e.g. dicentric formation or by counting micronuclei in 
T-lymphocytes.
Low dose  radiation  poses  a  particular  problem,  as  the  effects  it  has  on 
individuals,  both  in  the  short  term  and  in  the  long  term,  are  not  fully 
understood.  Moreover,  most  over-exposure  cases  involve  low  doses  of 
ionising radiation (Tucker,  2008).  A question that  needs  to  be addressed 
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regarding low doses is: is there a threshold below which radiation does not 
induce permanent or harmful aberrations? An adaptive response has been 
observed at  low doses,  where exposure at  low doses has  diminished the 
effect of exposure to a higher dose. It is important to assess risks at low 
doses of radiation in relation to occupational exposure (chronic) (Darroudi 
et  al,  2008),  because,  although  chronic  exposures  result  in  simpler 
aberrations, they are more likely to persist as the cells are able to survive 
with the unrepaired damage. Another difficulty is that biological methods 
may not  be sensitive or accurate  enough to  detect  the damage produced 
upon exposure to low doses. 
1.1.6 Chromosomal radiosensitivity
Radiosensitivity refers to how susceptible an organism or cell is to radiation. 
Individuals differ in their radiosensitivity, as different cell types may also 
differ. Lymphocytes are among the most radiosensitive cells in the body, in 
particular CD8+ cells,  which have been shown to be more radiosensitive 
than other lymphocyte subpopulations (Wilkins et al, 2002). Several factors 
affect  radiosensitivity,  some  being  external,  such  as  the  conditions  and 
stresses that a cell is exposed to prior to and/or during radiation exposure. 
For  example,  a  mixed lymphocyte  culture  may fare  better  than  separate 
cultures for different lymphocyte subpopulations because mixed populations 
may work in conjunction with one another to protect the population; also a 
mixed culture has probably undergone far less stress than those that were 
separated (Wilkins et al, 2002). Inherent factors may involve multiple genes, 
such as those involved in stress response, DNA repair and apoptosis. 
Certain  population  groups  have  been  shown  to  have  an  enhanced 
chromosomal  radiosensitivity.  Initially,  it  was  shown  that  chromosomal 
radiosensitivity  existed  among  patients  with  syndromes  pre-disposed  to 
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cancer,  such  as  Fanconi’s  anaemia,  Ataxia  Telangiectasia,  Nijmegen 
breakage syndrome (Sanford et al, 1989; Scott et al, 1999), whereas later it 
became apparent that chromosomal sensitivity to ionising radiation can be 
detected not only within these chromosomal fragility syndromes but also in 
many other cancer prone conditions (Sanford et al., 1989; reviewed in Scott 
et al., 1999, Baeyens, 2005). Radiosensitivity has been attributed to DNA 
repair gene defects (Preston, 1980; Parshad et al, 1983), such as mutations 
in the protein, Artemis, which result in hypersensitivity to agents known to 
induce DNA DSBs (Ma et al, 2002), defects in cell cycle checkpoint control 
(Little and Nagasawa, 1985), as well as in chromatin structure differences 
(Hittelman and Pandita, 1994) and defective apoptosis. 
1.2 Cytogenetic tests
Cytogenetic  tests  can  be  performed  to  examine  many different  types  of 
chromosomal  damage.   These  tests  are  used in  radiation  protection  (e.g. 
biological  dosimetry)  as  well  as  in  fundamental  radiobiological  research 
(e.g.  in vitro chromosomal radiosensitivity studies). There are a number of 
available  tests;  the most commonly used are  the micronucleus assay,  the 
dicentric assay and the Comet assay. The dicentric assay identifies damaged 
chromosomes in metaphase,  where a DSB or a  SSB is  mis-repaired and 
rejoined  to  another  chromosome  resulting  in  a  chromosome  with  two 
centromeres  and  acentric  fragments.  The  detection  of  dicentric 
chromosomes  on  Giemsa-stained  metaphases  can  be  a  time-consuming 
process. Another option is to use chromosomal banding techniques, which 
make the chromosomes identifiable from one another.  However,  this  test 
also requires time and skill to ensure accuracy. The comet assay or Single 
Cell  Gel  Electrophoresis  (SCGE)  assay  (Singh  et  al,  1988)  involves 
embedding the cells in agarose, then lysing them and applying an electric 
current.  Undamaged DNA remains  tightly organised  and associated  with 
proteins making it larger, and unable to move much along the gel. Damaged 
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DNA is more free to move, and results in a “tail”, which can be visualised 
using fluorescence. Different damage can be identified from this tail.
1.2.1 The micronucleus assay
Micronuclei appear as smaller versions of the main nucleus in the cytoplasm 
of  interphase  cells  (Baeyens,  2005),  and  they  are  indicators  of  more 
persistent cytogenetic damage. They can be formed in two different ways 
(Figure  3),  because  of  clastogenic  events  (such  as  exposure  to  ionising 
radiation)  or  aneugenic  events.  Clastogenic  events  pertain  to  the  loss  of 
chromosomal fragments that are a result of unrepaired DNA DSBs; they are, 
generally,  acentric  fragments.  Regarding  aneugenic  events,  whole 
chromosomes  may  lag  behind  during  mitosis  and  are,  consequently, 
excluded from the main nucleus. In both cases, nuclear membranes form 
around  these  chromosomal  fragments  or  whole  chromosomes,  and  they 
form micronuclei in the cytoplasm.   Most spontaneous micronuclei result 
from  aneugenic  events  and  are  therefore  centromere-positive,  whilst 
clastogenic agents, such as radiation, result in mostly centromere-negative 
micronuclei.
Figure 3: Overview of micronucleus formation  (Baeyens, 2005).
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The micronucleus assay was developed by Fenech and Morley (1985), and 
it has since been established and validated as an excellent tool for detecting 
radiation-induced  DNA  damage  (in  the  form  of  micronuclei).  The 
micronucleus  assay  involves  stimulating  cell  division  with  the  mitogen, 
phytohaemagglutinin  (PHA),  but  blocks  cytokinesis  with  cytochalasin-B, 
which prevents the polymerisation of actin filaments. This allows nuclei to 
divide but prevents completion of cell division. Micronuclei are counted in 
cells that have undergone a single nuclear division i.e. a binucleated cell. 
There are numerous advantages to the micronucleus assay, firstly because it 
is a simple and easy-to-use technique. It has clearly defined endpoints as 
shown in Figure 4, which indicates variations on what can be accepted as 
true  micronuclei.   It  has  been  adapted  to  a  high-throughput  automated 
process involving the slide scanning system Metafer (Schunck et al, 2004). 
It is useful in immediate dose assessment. It also fulfils the criteria for a 
reliable biomonitoring system – 1) blood is an easily collected specimen 
with little discomfort to the patient, 2) there is a set parameter for detecting 
the number of micronuclei, and 3) the method is well-established. Reference 
and  limit   values  may  need  to  be  established  in  many  individual  and 
population groups and for different types of ionising radiation. 
However,  one  disadvantage  is  that  the  assay cannot  distinguish  between 
spontaneous damage and radiation-induced damage in low doses (usually 
below 0.3  Gy).  This  is  because  the  number  of  micronuclei  produced  is 
similar  to  unexposed controls  and the micronuclei  count  is  usually quite 
low. The micronucleus assay can be adapted to be used in conjunction with 
other techniques, such as Fluorescence In Situ Hybridisation (FISH). FISH 
with a pancentromeric probe coupled with the micronucleus assay is able to 
distinguish between spontaneous damage and radiation-induced damage in 
low doses (usually below 0.3 Gy).
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Figure 4: Schematic drawings of binucleated cells with true micronuclei, (a) 
two micronuclei of different sizes – 1/3 and 1/9 of main nuclei diameter, (b) 
micronuclei that are touching the main nuclei, but not overlapping it, (c) two 
micronuclei, and a binucleated cell with a nucleoplasmic bridge, (d) many 
micronuclei in a binucleated cell (Fenech, 2000).
There is variation among unexposed individuals regarding their micronuclei 
counts, and various factors can affect them, including age and sex (Fenech 
et  al,  1994;  Thierens  et  al,  1996).  Studies  have  found  that  micronuclei 
counts increase with age,  and that higher counts are found in females as 
compared to males (Fenech et  al,  1994; Thierens et  al,  1996). Pala et  al 
(2008) showed that  increasing numbers of centromere-negative micronuclei 
coincided with increasing doses of ionising radiation,  which corroborates 
the assumption that radiation induces centromere-negative micronuclei. 
 
1.2.2 The micronucleus assay combined with the pan-centromeric probe
The  pan-centromeric  probe  allows  clastogenic,  centromeric-negative 
micronuclei, and aneugenic, centromere-positive micronuclei, events to be 
distinguished. This means that background micronuclei can be distinguished 
from radiation-induced micronuclei. 
As has been stated,  micronuclei  can form through different  mechanisms. 
The  combination  of  the  micronucleus  assays  with  FISH  using  a  pan-
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centromeric  probe  can  suggest  how the  micronuclei  form as  a  result  of 
radiation  or  not.  Figure  5  shows  a  cell  that  formed  micronuclei  either 
because  of  genomic  instability  or  a  genotoxic  agent.  It  also  shows  that 
through the use of the micronucleus assay combined with a pan-centromeric 
probe,  how  the  micronuclei  were  formed  can  be  determined.  Further 
analysis of the number of centromeric signals in the CM+MN can possibly 
offer additional information on the nature of the damage sustained.
A pan-centromeric  probe will  hybridise  to  all  the  centromeres  of  all  the 
chromosomes, including any in the micronuclei and in the main nuclei. The 
probe bound in the main nuclei acts as an internal control, and hybridisation 
is  deemed  successful  if  the  probe  has  indeed  bound  to  the  centromeres 
present in the main nuclei. Slides can be visualised by using fluorescence 
microscopy. Although commercial pan-centromeric probes are available it is 
more  feasible  to  make  an  in-house  probe.  Primarily,  it  is  relatively 
inexpensive to prepare and makes it more affordable for the laboratory and 
the patient.
Figure  5:  Depiction  of  the  formation  of  micronuclei  through  different 
mechanisms,  and  the  use  of  the  CBMN  assay  and  FISH  with  pan-
centromeric probes to determine how the micronuclei formed (Iarmarcovai 
et al, 2006).
17
Figure  6  gives  an  example  of  a  binucleated  (BN)  cell  with  a  single 
micronucleus,  which  has  been  fluorescently-labelled  with  a  centromeric 
(red)  probe.  The  nuclei  are  counterstained  with  DAPI.  The  centromeric 
signals are clear and visible in the main nuclei.
      
Figure 6: A binucleate cell with a single micronucleus under DAPI (blue 
nuclei) and fluorescent filters for centromeric probes (red signals). 
1.3 Human Immunodeficiency Virus (HIV)
Classification
Group: Group VI (ssRNA-RT)
Family: Retroviridae
Genus: Lentivirus
HIV is a rather large spherical virus with a diameter of about 120 nm. It has 
two copies of positive single-stranded RNA, which encode the virus's nine 
genes. The RNA is encapsidated in a conical capsid made from its own viral 
protein, p24. HIV infects cells involved in the immune system, including 
CD4+  T-lymphocytes,  macrophages  and  microglial  cells.  HIV results  in 
immunodeficiency  in  infected  people  eventually  leading  to  Acquired 
ImmunoDeficiency Syndrome  (AIDS)  when  CD4 counts  fall  below 200 
cells/mm3.  HIV  infection  is  treated  with  Highly  Active  AntiRetroviral 
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Treatment (HAART), where the drugs taken target various stages during the 
HIV life cycle. A number of different drugs with different targets are taken 
as HIV has a high mutation rate and can develop resistance very quickly. A 
viral  population may have many “quasispecies” with a number of highly 
heterogeneous  sequences  (Freed,  2001).  HIV also  creates  and  maintains 
several  reservoirs where viruses integrate into cells and remain latent for 
long periods of time, again allowing the virus to evade the immune system. 
Cells with latent proviruses may sometimes be infected again. A productive 
superinfection allows old  sequences  of  the virus  to  recombine with new 
ones, leading to one cell producing several strains (Jeeninga et al, 2008).
The life cycle of HIV-1 is depicted in Figure 7, and briefly described here. 
The virus enters the cell by binding its glycoproteins gp120 to the host cell's 
CD4 receptor and co-receptor CXCR4 or CCR5. Gp41 catalyses membrane 
fusion, where the virus and cellular membranes can fuse allowing the viral 
core to enter into the cytoplasm (Freed, 2001). Fusion requires cholesterol 
and the receptors  to  localise  at  the fusion  site  for  it  to  occur.  Fusion is 
multistep  where  firstly  the  contents  of  both  the  membranes  are  mixed, 
termed hemifusion, secondly, the fusion pore is formed when gp41 inserts 
directly into the target membrane and lastly the pore is enlarged (Campbell 
and Hope, 2008; Freed, 2001). Not all viruses enter the cell through this 
pathway, many are passively endocytosed by the cell. Upon entry into the 
cell, the viral genome is uncoated and it is converted into double-stranded 
DNA via its own pol-encoded enzyme reverse transcriptase (Freed, 2001). 
The newly transcribed viral DNA is transported actively across the nuclear 
envelope into the nucleus as part of the PIC (pro-integration complex). The 
PIC is made up of both viral and cellular proteins that associate with the 
viral  DNA (Freed,  2001).   PIC also allows HIV-1 to infect non-dividing 
cells (Freed, 2004). Another virally encoded protein, integrase, catalyses the 
integration of the viral DNA into the host cell genome (Freed, 2001). Once 
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integrated,  the provirus can remain latent for several  years and acts as a 
cellular  gene.  HIV-1 has  several  novel  proteins  that  are  adapted  to  take 
advantage of the host cell. Various viral RNAs are transcribed using host 
machinery. The viral protein TAT acts upon TAR to stimulate transcription 
and gene expression. Some viral RNAs that are transcribed are not spliced 
or only partially spliced, and cannot be exported from the nucleus according 
to host cell mechanisms. One of the first proteins made by the virus is the 
REV protein, which facilitates the export of these unspliced and/or partially 
spliced  RNAs (Freed,  2001).  The  viral  Gag proteins  are  responsible  for 
encapsidating the viral RNA genome, the assembly of the virus particle and 
its release (Freed, 2001). The virus particle buds out of the cell, taking some 
of  the  host  membrane  proteins  with  it,  thereby further  evading  the  host 
immune response.
Figure 7: Schematic view of the life-cycle of HIV-1 (Freed, 1998).
20
HIV infection can result in various processes of the cell being dysregulated. 
One such example is apoptosis. HIV infection activates the immune system, 
which  remains  constantly  activated,  disrupting  the  normal  expression  of 
proteins involved in the cell cycle. This leads to T-cell dysregulation, and 
the T-cells become more susceptible to apoptosis (Galati et al, 2002). HIV-1 
has also been shown to have enhanced oxidative stress because of reactive 
oxygen  species,  which  may  help  explain  impairment  of  T-cell 
responsiveness  and  enhanced  T-cell  apoptosis  (Aukrust  et  al,  2005). 
Oxidative stress can damage DNA, and one of the lesions formed is 8-oxoG. 
These lesions are repaired by BER. Disturbed redox balances and increased 
levels  of  8-oxoG  lesions  are  found  in  HIV+  individuals  compared  to 
uninfected controls, with the 8-oxoG levels correlating to the  viral RNA 
copy numbers (Aukrust et al, 2005). It has also been observed that these 
cells  have  a  reduced  capacity  to  repair  this  damage  because  of  a 
downregulation in DNA glycosylase activity for repair (Aukrust et al, 2005). 
The  oxidative  stress  may  be  a  result  of  the  increased  activity  of 
inflammatory cytokines (Aukrust et al, 2005).
There  are  approximately  33  million  people  living  with  HIV worldwide, 
about  67  % of  whom reside  in  Sub-Saharan  Africa.  About  90  % of  all 
children with HIV live in Sub-Saharan Africa,  and in 2007, 75 % of all 
AIDS  deaths  occurred  in  Sub-Saharan  Africa  (The  AIDS  2008  Impact 
Report). The five countries with the highest prevalence all lie in southern 
Africa.  South  Africa  has  the  most  severe  epidemic  in  the  world,  with 
approximately  5.7  million  of  its  population  infected  (about  18  % of  its 
population),  and  over  350  000  deaths  attributed  to  HIV/AIDS  related 
causes; it  is estimated that 1000 AIDS related deaths occur every day in 
South Africa. South Africa’s infection rate is among the worst estimated at 
1500 new infections occurring per day (500 000 people newly infected each 
year). There are a number of contributing factors to the massive epidemic: 
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poverty, sexual violence, social instability, inequality, low status of women, 
high levels  of  sexually transmitted  infections,  high mobility,  limited  and 
uneven access to quality health care and poor leadership in response to the 
epidemic (The AIDS 2008 Impact Report).
In South Africa, a large proportion of the population is HIV+, and may be in 
an occupation where exposure to ionising radiation may occur. Also, with 
HAART and continuing treatment for HIV the  epidemic is changing and 
people are living longer, and they may develop cancer. It is important to 
ensure  that  safety  criteria  are  appropriate  for  all,  and  that  treatment  for 
cancer can be catered for a more representative population.
Biomonitoring can identify individuals that are at higher risk with regards to 
radiation exposure(Angerer  et  al,  2007),  such as in the unique setting of 
South  Africa  where  a  significant  proportion  of  the  population  is  HIV 
positive and in a situation where occupational exposure to ionising radiation 
may occur. Recently published data (Baeyens et al, 2010) has indicated that 
HIV positive  individuals  may be more  radiosensitive  than  HIV negative 
individuals, and would therefore be more at risk to radiation exposure in the 
workplace.  Within  South  Africa's  unique  population,  the  relationship 
between HIV and radiosensitivity needs to be further explored, in order to 
better assess the risks involved with regards to the use of ionising radiation 
both in the workplace and in radiation therapy. 
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Aim
The  general  aim  of  this  study  was  to  develop  a  human  DNA  pan-
centromeric  marker  in  order  to  differentiate  between  spontaneous 
micronuclei and radiation-induced micronuclei. It is especially important to 
understand what occurs in response to exposure to low doses of ionising 
radiation. The majority of accidental exposures in the workplace occur in 
the  low  dose  range,  and  the  sensitivity  of  the  tests  currently  used  is 
restricted to 0.2 Gy – 0.3 Gy. The combination of a pan-centromeric marker 
with the micronucleus assay would further refine the low dose radiation-
induced damage detection. The use of a combined automatic micronucleus 
pan-centromeric probe  scoring system would  facilitate the development of 
biomonitoring radiation  workers. In cases of massive radiation accidents, 
this technique will allow an accurate assessment of exposure. A financially 
viable and time efficient method for developing and using a pan-centromeric 
probe needs to be explored.  
Objectives
• Evaluate  and  optimise  two methods  used to  create  the  pan-centromeric 
probe,  and  compare  the  two  probes  with  one  another  and  with  a 
commercial probe after hybridisation to metaphase slides. Based on these 
results one method was selected.
• Apply  the  selected  probe  in  a  biological  dose-dependent  assay,  where 
lymphocytes  from healthy donors  are  irradiated  with different  doses  of 
gamma  radiation,  and  the  total  number  of  micronuclei,  the  number  of 
micronuclei with or without a signal are scored.
• Compare  automated  and  semi-automated  scoring  of  micronuclei  on  the 
MetaFer system.
• Apply the probe to evaluate the base line number of micronuclei in HIV-
positive and HIV-negative donors.
• Establish  a  biological  dose-dependent  assay  in  HIV-positive  and  HIV-
negative lymphocytes  irradiated at different doses.    
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CHAPTER TWO – MATERIALS
2.1 Sample collection
Fresh blood samples were collected by means of venepuncture in lithium-
heparin  or  EDTA tubes.  Signed informed consent  was  received  from all 
volunteers.  Data  regarding  age,  smoking  habits  and  gender  were  also 
collected,  as  age,  smoking  and  gender  can  influence  the  micronucleus 
values. Samples were all coded. This study was approved by the Human 
Research Ethics Committee, University of the Witwatersrand, Johannesburg, 
South Africa (M090475).
2.1.1 Control samples
Twenty blood samples were collected from healthy donors.  Donors were 
from the Somatic Cell Genetics Unit,  Department of Molecular Medicine 
and Haematology, University of the Witwatersrand, South Africa and at the 
Department of Basic Medical Science, University of Ghent, Belgium. Blood 
samples  for  culturing  micronucleus  assays  and  metaphase  cultures  were 
collected in Li-heparin tubes. Blood was also collected for DNA extractions 
from healthy male donors in EDTA tubes. Male donors were used so that the 
centromeres  of  all  autosomal  chromosomes  as  well  as  the  X  and  Y 
chromosomes, were acquired. Ten samples were used from healthy donors 
for culturing purposes, and all cultures were performed in duplicate, and the 
rest were used as controls in the HIV study.
2.1.2 HIV samples
Thirty-five blood samples were collected in Li-heparin tubes from patients 
at the HIV centre, Helen Joseph Hospital, Johannesburg, South Africa. Data 
regarding CD4 counts was collected from the patients and samples were 
excluded  if  their  CD4  counts  fell  below  200  cells/mm3  .  Previous  data 
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(Baeyens et al, 2010) has shown that cultures from HIV positive samples 
with a CD4 count below 200 cells/mm3 produce too few cells to adequately 
perform a MN assay. Samples were also excluded if the patients were on 
ARV  treatment,  as  the  treatment  could  interfere  with  the  micronucleus 
assay. Nineteen HIV+ samples and thirteen HIV- samples were used for the 
first part of the HIV study, and eight HIV+ samples and four HIV- samples 
were used for the second part of the study. 
2.2 Product list (see Appendix A)
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CHAPTER THREE – METHODS
3.1 Micronucleus assay
Two methods were used for the micronucleus tests. Method 1 was used in 
South  Africa  (Somatic  Cell  Genetics  Unit,  Department  of  Molecular 
Medicine and Haematology, University of the Witwatersrand) and Method 2 
was used in Belgium (Department of Basic Medical Science, University of 
Ghent).  The  differences  in  the  methods  were  dependent  on  what  was 
available  in  the  different  laboratories,  and  how  the  irradiations  were 
performed, and did not affect the validity of the results.
3.1.1 Method 1 
4.5  ml  of  pre-warmed  complete  medium (Appendix  A)  was  added  to  a 
culture flask (25 cm3). 500 μl of whole blood was added to this. The cultures 
were irradiated or mock-irradiated. 100 μl of phytohaemagglutinin (PHA) 
was added to the cultures. The cultures were incubated at 37 °C, upright, 5 
% CO2. Twenty-three hours later, 20 μl of cytochalasin B (Appendix A) was 
added to the culture.  Seventy hours after  adding PHA, the cultures were 
harvested.  The  blood  mixture  was  transferred  to  a  15  ml  tube  and 
centrifuged at 1000 rpm for 8 minutes. The supernatant was removed. 7 ml 
of cold KCl (Appendix A) was added dropwise while vortexing. The tubes 
were centrifuged at 1000 rpm for 8 minutes. The supernatant was removed 
and 7 ml of cold 4:1:5♦ methanol:acetic acid:Ringer (Appendix A) fixative 
was added dropwise while vortexing. Ringer acts as a buffer preventing the 
lymphocytes from bursting. The tubes were stored at 4 °C overnight. The 
following day, the cultures were further fixed. The tubes were centrifuged at 
1000  rpm  for  8  minutes.  The  supernatant  was  removed.  5  ml  of  4:1 
methanol:acetic acid was added while vortexing. This was repeated until the 
solution was clear. The samples were centrifuged at 1000 rpm for 8 minutes. 
The  supernatant  was  removed,  leaving  enough  fixative  (usually  about 
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500µl♣)  to  resuspend the pellet.  The tube was vortexed to  resuspend the 
pellet,  and 40 µl of the suspension was dropped onto a clean glass slide 
(cleaned in methanol) and spread as much as possible by tilting the slide 
back and forth. The slides were air-dried and kept at room temperature.
♦ 10:1:11 methanol:acetic acid:ringer fixative was used when slides were prepared 
for manual scoring. Subsequently, 4:1 methanol:acetic acid fixative was replaced 
with 10:1.
♣ samples that were manually scored were concentrated more and spread out less
3.1.2 Method 2
3 ml of pre-warmed complete medium (Appendix A) with 10 % FCS was 
added to a culture flask, and 1.5 ml was added to a round-bottomed tube. 
500 μl of whole blood was added to this. The cultures were irradiated or 
mock-irradiated.  The contents of the tube were transferred to  the culture 
flask containing the 3 ml  of  medium. 100 μl  of  PHA was added to  the 
cultures. The cultures were incubated at 37 °C, upright, 5 % CO2. Twenty-
three hours later, 20 μl of cytochalasin B was added to the culture. Seventy 
hours after adding PHA, the cultures were harvested. The blood mixture was 
transferred to a 15 ml tube and centrifuged at 1000 rpm for 8 minutes. The 
supernatant  was  removed.  7  ml  of  cold  KCl  was  added dropwise  while 
vortexing.  The  tubes  were  centrifuged  at  1000  rpm for  8  minutes.  The 
supernatant was removed and 7 ml of cold 4:1:5 methanol:acetic acid:ringer 
fixative was added dropwise while vortexing. The tubes were stored at 4 °C 
overnight.  The  following  day,  the  cultures  were  fixed.  The  tubes  were 
centrifuged at 1000 rpm for 8 minutes. The supernatant was removed. 5 ml 
of 4:1 methanol:acetic acid was added while vortexing. This was repeated 
until the solution was clear. The samples were centrifuged at 1000 rpm for 8 
minutes.  The  supernatant  was  removed,  leaving  enough fixative  (usually 
about 500 µl) to resuspend the pellet. The tube was vortexed to resuspend 
the pellet, and 40 µl of the suspension was dropped onto a clean glass slide 
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(cleaned in methanol) and spread as much as possible by tilting the slide 
back and forth. The slides were air-dried and were kept at room temperature.
3.2 Classic cytogenetic test for chromosomal aberrations
Metaphase  preparations  were  done  to  test  whether  the  pan-centromeric 
probes were hybridising to all centromeres of all chromosomes. 
4.5 ml of complete medium (Appendix A, complete medium for method 1) 
was added to a culture flask. 500 μl of whole blood was added to this, and 
100 μl of PHA was also added. The culture was incubated at 37 °C, 5 % 
CO2, horizontally with the caps slightly open. Forty-three hours later, 100 μl 
of colcemid (Gibco) was added to the cultures to stall the cell division at 
metaphase. Forty-seven hours after start-up the cultures were harvested. The 
blood mixture was transferred to a 15 ml tube and centrifuged at 1000 rpm 
for 8 minutes. The supernatant was removed. 5 ml of KCl, prewarmed to 37 
°C, was added dropwise while vortexing. The tubes were incubated at 37 °C 
for  15  minutes.  They were  centrifuged  at  1000 rpm for  8  minutes.  The 
supernatant was removed and 5 ml of cold 3:1 methanol:acetic acid fixative 
was added while vortexing. This was repeated until the solution was clear, 
then  stored  at  4  °C.  The  samples  were  centrifuged  at  1000  rpm  for  8 
minutes.  The  supernatant  was  removed,  leaving  enough  fixative  to 
resuspend the pellet. The tube was vortexed to resuspend the pellet, and 50 
μl  of  the  suspension  was  dropped  onto  a  clean  glass  slide  (cleaned  in 
methanol)  from 30 cm. The slides were air-dried and were kept at  room 
temperature.
28
3.3 Irradiation procedures
Irradiations were performed at Medical Physics, Charlotte Maxeke Hospital, 
South  Africa  and  at  the  Institute  for  Nuclear  Sciences  (INW),  Belgium. 
Safety procedures were followed for all irradiations, including the wearing 
of  personal  radiation  dosimeters.  Irradiations  were  performed  by  a 
competent technician.
3.3.1 Dose Response study
Doses in the dose response study were 0.05 Gy, 0.1 Gy, 0.2 Gy, 0.3 Gy, 0.5 
Gy, 0.75 Gy, 1 Gy, 2 Gy. Samples were also mock-irradiated as controls. 
Gamma radiation from a cobalt-60 (Co-60) source was used. Ten samples 
were collected in total, and perfomed in duplicate.
At the INW, the irradiations for the doses 0.05 Gy – 0.2 Gy were performed 
in a heated water bath (37 °C) 30 cm from the source at a dose rate of 0.01 
Gy/min; the irradiations for the doses 0.3 Gy – 2 Gy were performed in a 
heated water bath (37 °C) at a dose rate of 0.32 Gy/min. The irradiations 
carried out at Medical Physics, Charlotte Maxeke Hospital, Johannesburg, 
South Africa were performed in a water bath at ambient temperature at a 
dose rate of 1.52 Gy/min.
3.3.2 HIV study
HIV  samples  were  irradiated  at  Medical  Physics,  Charlotte  Maxeke 
Hospital,  South Africa with a 6 MV photon beam from a medical linear 
accelerator  (Siemens  Healthcare,  Erlangen,  Germany).   The  HIV  study 
comprised two parts. HIV samples collected for the first part of the study 
were irradiated at doses of 2 Gy and 4 Gy, and mock-irradiated. The culture 
flasks were fixed at a depth of 11.5 cm in a water bath (30 cm × 30 cm × 30 
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cm) and placed at the isocentre of the beam, where the field size was 10 cm 
× 10 cm.  The doses were delivered at a dose rate of 1.33 Gy/min. These 
irradiated samples were manually scored. The samples collected during the 
second  part  of  the  study  were  not  irradiated  and  were  scored  semi-
automatically. 
3.4 Slide Staining 
Slides  were stained depending on what  they were to  be used for.  Slides 
stained  with  acridine  orange  were  scored  manually  for  micronuclei,  and 
slides stained with DAPI alone were scored automatically on the MetaFer 
for micronuclei.
3.4.1 Acridine Orange Staining
Slides were immersed in acridine orange working solution (Appendix A) for 
one minute, rinsed in distilled water, and immersed in acridine orange buffer 
for  one  minute.  The slides  were  removed from the  buffer,  and 20 μl  of 
buffer was dropped onto the slides to avoid drying out. A glass coverslip 
was carefully placed over the slide avoiding air bubbles, and sealed with 
rubber  cement.  The  slides  were  manually  scored  for  micronuclei  within 
three days (see section 3.6). Acridine orange stains the cytoplasm orange 
and the nuclei green.  
3.4.2 DAPI Staining
Slides were stained with a drop of Vectashield with DAPI (Vector Labs). 
The nuclei were stained blue, as DAPI intercalates the DNA. These slides 
were scored automatically on the Metafer 10 × objective (see section 3.6).  
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3.5 Fluorescent In Situ Hybridisation (FISH)
The  pan-centromeric  probe  was  applied  to  micronucleus  and  metaphase 
slides by means of FISH methodologies. Slides were dehydrated prior to 
hybridisation in order to maintain chromosome morphology and wash away 
any fixative still present on the slide. Some pretreatments were tried in order 
to obtain optimal FISH results, and are described below. The methods used 
to  create  the  pan-centromeric  probes  are  described.  Hybridisation  and 
washing, methods are described below, were performed on these slides, and 
where indicated the protocols for the commercial STARFISH© denaturing 
solution pan-centromeric probe are also described.
3.5.1 Slide preparation
Slides were dehydrated in an ethanol (Merck) series (70 %, 90 %,100 %) for 
5 minutes each and aged overnight at room temperature. 
Pretreatments
Various  pretreatments  were  tried  in  order  to  improve  hybridisation  and 
lower background. The desired result was to have no cytoplasm, which may 
restrict the pan-centromeric probe from entering the nucleus and hybridising 
to the chromosomes. The following pretreatments were tried: 
3.5.1a) RNase only pretreatment
The slides were incubated with 100 µg/ml RNase (Roche) for one hour at 37 
°C, then washed in 2 × SSC for 5 minutes followed by another 5-minute 
wash in PBS. The slides were dehydrated in a room temperature ethanol 
series. Controls received no treatment. FISH was performed on these slides.
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3.5.1b) RNase and pepsin pretreatment I
The slides were incubated with 100 µg/ml RNase (Roche) for one hour at 37 
°C, then washed in 2 × SSC for 5 minutes followed by another 5-minute 
wash in PBS. The slides were treated with pepsin for 2 minutes in a moist 
chamber at room temperature. The slides were washed in PBS for 5 minutes, 
then dehydrated in a room temperature ethanol series. Controls received no 
treatment. FISH was performed on these slides.
3.5.1c) RNase and pepsin pretreatment II
Slides were treated with 100 µg/ml RNase / 2 × SSC for thirty minutes at 37 
°C  in  a  moist  chamber,  then  washed  three  times  in  2  ×  SSC  at  room 
temperature for five minutes each. The slides were dehydrated in a room 
temperature  ethanol  series  and air-dried.  The  slides  were  incubated  with 
0.001 % pepsin /  0.01 M HCl at  37 °C for  5  minutes.  The  slides  were 
washed in PBS for 5 minutes, and dehydrated in a room temperature ethanol 
series.  The  slides  were  post-fixed  in  postfixation  buffer  (Appendix  A), 
followed by a 5-minute wash in 4 % paraformaldehyde (Appendix A), and a 
5-minute wash in PBS. The slides were dehydrated in  room temperature 
ethanol series. FISH was carried out on these slides.
3.5.1d) Pepsin only pretreatment 
The slides were washed for two minutes in a pepsin solution at 37 °C. They 
were then fixed in 1 % formaldehyde followed by two washes in 2 × SSC 
for 5 minutes each. They were dried and dehydrated in a room temperature 
ethanol series. FISH was performed on the slides.
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3.5.2 Probe preparation
Two different methods are used to make a pan-centromeric probe; the first 
utilises a human DNA sequence clone called p82H, and the second involves 
making a synthetic probe from human DNA with primers designed to target 
the centromeres. Both products are labelled by means of nick translation 
with fluorescent SpectrumOrange dUTPs to be used as a probe in FISH. A 
commercial  probe,  STARFISH©  pan-centromeric  probe,  was  compared 
with the made probes according to their hybridisation to metaphase slides. 
3.5.2.1 p82H probe 
p82H is  a  2.4  kb human DNA sequence.  It  is  a  member of  the  alphoid 
repeated sequence family. The p82H clone hybridises to the centromeres of 
all chromosomes (Mitchell et al, 1985; Aleixandre et al, 1987). The p82H 
plasmid  is  grown  in  Escherichia  coli and  extracted  using  a  plasmid 
extraction kit (Qiagen).
Bacterial culture
A single bacterial colony from an agar plate was planted in 5 ml of Luria 
Broth  (LB)  medium (Appendix  A)  containing  1  mg/ml  ampicillin  using 
sterile techniques. This starter culture was incubated for 6-8 hours at 37 °C 
on a  shaking incubator.  The turbidity,  indicating bacterial  growth,  of the 
medium was observed after the incubation period. Once the turbidity was 
sufficient, the starter culture was diluted in 200 ml of fresh LB medium in 
an Erlenmeyer flask stoppered with cotton wool and tinfoil, and incubated 
for approximately 16 hours at 37 °C on the shaking incubator under sterile 
conditions. After 16 hours, the cultures were transferred to 50 ml NUNC 
tubes and centrifuged at 6000 × g for 15 minutes. The supernatants were 
discarded, and the pellets could be used immediately for plasmid extraction 
described  below.  Glycerol  stocks  were  made  from the  starter  culture  by 
adding 800 µl of the starter culture to 200 µl of glycerol, mixing and storing 
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at −70 °C. These could be used to start up new cultures for plating. 
Plasmid extraction
Plasmids were extracted using Qiagen’s Plasmid Midi Kit as per protocol 
(see Appendix A). Briefly, the pellet was resuspended in 4 ml Buffer P1. 4 
ml of Buffer P2 was added, and mixed by inverting six times. The solution 
turned a bright blue colour, and was homogeneous when completely mixed. 
The solution was incubated at room temperature for five minutes. 4 ml of 
Buffer P3 was added, and mixed by inversion. A white precipitate formed 
and the solution became less viscous; the solution also lost its blue colour. 
This was incubated on ice for fifteen minutes. The solution was centrifuged 
at 20000 × g for thirty minutes at 4 °C, and the supernatant, containing the 
DNA, was transferred to a new 50 ml NUNC tube, which was centrifuged 
again at 20000 × g for fifteen minutes at 4 °C to remove excess precipitate. 
The supernatant was transferred to the QIAGEN-tip 100, which had been 
equilibrated by allowing 4 ml of Buffer QBT to flow through it, and allowed 
to flow through the tip. The QIAGEN-tip 100 was then washed twice with 
10 ml of Buffer QC. The DNA was eluted with 5 ml Buffer QF preheated at 
65 °C. The DNA was precipitated as follows. 3.5 ml of isopropanol (room 
temperature) was added to the eluted DNA, and centrifuged at 15000 × g for 
30 minutes at 4 °C. The supernatant was discarded. 2 ml of 70 % ethanol 
(room temperature) was added to wash the pellet. The tube was centrifuged 
at 15000 × g for 10 minutes. The supernatant was carefully decanted. The 
pellet was air-dried for 5-10 minutes before adding 100 µl of TE Buffer 
(Promega)  to  redissolve the pellet.  This was  left  at  room temperature to 
dissolve,  then  stored  at  −20  °C.  2  µl  of  the  extracted  DNA  was 
electrophoresed on a 2 % agarose gel against lambda DNA to determine if 
the extraction was successful,  and evaluate the quantity of plasmid DNA 
(Figure 16, Appendix B). 
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3.5.2.2 Synthetic probe
Specific primers used can  isolate and amplify the centromeric DNA (Weier 
et al, 1991). For this method, male DNA has to be used to obtain X, Y and 
autosomal centromeres. The PCR product can then be purified. 
DNA extraction: In-house phenol-chloroform method
Blood collected in EDTA tubes was centrifuged at 1500 rpm for 10 minutes 
at room temperature. The serum was removed with Pasteur pipettes. 1 ml of 
the buffy coat was aspirated up and added to 5 ml (1:5 ratio) of ice-cold red 
blood cell lysis buffer (Roche) in a 15 ml tube. This was incubated on ice 
for  15  minutes,  vortexing  every  5  minutes  to  lyse  the  red  blood  cells, 
indicated by the solution becoming less opaque. It was then centrifuged at 
1500 rpm for 10 minutes at 4 °C. The supernatant was removed from the 
small white pellet at the bottom of the tube. 2 ml of red blood cell lysis 
buffer (at room temperature) was added to the pellet and vortexed. The tube 
was centrifuged at 1500 rpm for 10 minutes at 4 °C. The supernatant was 
removed as much as possible. 4 ml of proteinase-K lysis buffer (Appendix 
A) was added to the pellet and aspirated to resuspend. 320 μl of 10 mg/ml 
proteinase-K (Roche)  was added and mixed well with the solution ensuring 
that it was homogeneous. The solution was incubated at 56 °C for one hour, 
mixing every fifteen minutes to  digest  proteins.  4  ml of  phenol  (Sigma-
aldrich) and 4 ml of chloroform were added to the solution and vortexed 
vigorously for one minute. The solution was centrifuged at 6000 rpm for 10 
minutes at 4 °C. It separated into three layers, and the top layer, containing 
the  DNA,  was  transferred  to  a  new  tube.  2  ml  of  phenol  and  2  ml  of 
chloroform were added to this, vortexed and centrifuged at 6000 rpm for 10 
minutes at 4 °C. The top layer was transferred to a new tube, and 4 ml of 
chloroform was added to it, vortexed and centrifuged at 6000 rpm for 10 
minutes at 4 °C. This was repeated until the solution was clear and no more 
white precipitate was present. The top layer was transferred to a new tube, 
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and 2.5 × the volume of ice-cold 100 % ethanol was added to the solution in 
order to precipitate the DNA. It was centrifuged at 6000 rpm for 10 minutes 
at 4 °C, and the supernatant was discarded. 2.5 ml of ice-cold 70 % ethanol 
was added to the pellet and centrifuged at 6000 × g for 10 minutes at 4 °C. 
The supernatant was discarded and the pellet air-dried for about 30 minutes 
upside down. The pellet was resuspended in 50 µl 1 × TE buffer, and left at 
room temperature to dissolve overnight. The concentration was determined 
on a NanoDrop spectrophotometer.
Polymerase Chain Reaction (PCR)
PCR was set up on ice and performed on thermocycler, Eppendorf, with the 
primers: 
Forward primer: 5’-GAA GCT TAA CTC ACA GAG TTG AA-3’ (Weier et 
al, 1991);
Reverse primer: 5’-GCT GCA GAT CAC AAA GAA GTT TC-3’ (Weier et 
al, 1991).
Table 1: Reagent concentrations and volumes for PCR
REAGENT
STOCK 
CONCENTRATION
FINAL 
CONCENTRATION
VOLUME (µl) 
× 1
DNA 250 ng
Forward primer (Operon 
biotechnologies)
100 µM 1.2 µM 1.2
Reverse primer (Operon 
biotechnologies)
100 µM 1.2 µM 1.2
10 × NH4 reaction buffer 
(Bioline)
10 × 1 × 10
MgCl2 (Bioline) 10 mM 1.6 mM 16
dNTP mix (Promega) 10 mM 100 µM 1
BIOTAQ DNA polymerase 
(Bioline)
5 U/l 5 U 1
dH2O - - Up to 100
TOTAL 100
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The PCR reaction was performed on the following programme (Weier et al, 
1991):
95 °C 10 minutes
96 °C 1 minute
45 °C 1 minute       30 cycles
72 °C 1 minute
72 °C 5 minutes
  4 °C ∞
5 μl of the PCR product was electrophoresed on a 2 % agarose gel against a 
100 bp DNA ladder (Fermentas). The reaction was deemed successful when 
two  bands  were  visible  at  the  sizes  of  175  bp  and  345  bp  (Figure  18, 
Appendix B). The remainder of the reaction was stored at 4 °C. 
PCR purification
PCR  purification  was  performed  by  means  of  PCR  purification  kits 
following their protocols.
1)  BioSpin PCR amplicon purification kit (South Africa)  
Two volumes of Binding Buffer were added to one volume of PCR product, 
and mixed by vortexing. The solution was added to the column, inserted into 
a collection tube, and centrifuged for one minute at 6000 × g binding the 
sample  to  the  column.  The  flowthrough  was  discarded,  and  the  column 
reinserted into the same collection tube. 650 μl of Wash Buffer was added to 
the column, and centrifuged at 12000 × g for one minute. The flowthrough 
was discarded and 650 µl of Wash Buffer was added again, and centrifuged 
at  12000  ×  g  for  one  minute.  The  flowthrough  was  discarded  and  the 
column dried by centrifuging it at 12000 × g for one minute. The column 
was transferred to a 1.5 ml microcentrifuge tube. 30 μl of purified molecular 
grade water was added to the column and incubated for one minute at room 
temperature. It was then centrifuged at 12000 × g for one minute to elute the 
37
DNA. The column was discarded and the eluted DNA stored at −20 ºC. The 
concentration of the DNA was determined using a spectrophotometer. 
2)   High Pure PCR Product Purification Kit (Roche) (Belgium) 
The  PCR  product  (approximately  100  µl)  was  transferred  to  a  1.5  ml 
microcentrifuge tube. 500 μl of Binding Buffer was added to the product 
and mixed well  by means of aspirating up and down. This solution was 
transferred to a High Pure Filter Tube (polypropylene tubes with two layers 
of glass fibre fleece) inserted into a Collection Tube (polypropylene tubes), 
and centrifuged for sixty seconds at maximum speed on a microcentrifuge at 
room  temperature.  The  flowthrough  was  discarded  from  the  Collection 
Tube, and the Filter Tube reinserted into the same Collection Tube. 500 μl of 
Wash Buffer was added to the Filter Tube, and centrifuged for sixty seconds 
at  maximum speed.  The flowthrough was discarded,  and the Filter  Tube 
reinserted into the same Collection Tube. 200 μl of Wash Buffer was added 
to the Filter Tube, and centrifuged for sixty minutes at maximum speed. The 
flowthrough  and  Collection  Tube  were  discarded.  The  Filter  Tube  was 
inserted into a new 1.5 ml microcentrifuge tube. 50 μl of Elution Buffer was 
added to the Filter  Tube,  and centrifuged for sixty seconds at  maximum 
speed. The Filter Tube was discarded and the eluted DNA was stored at −20 
ºC.  The  concentration  of  the  eluted  DNA  was  determined  on  a 
spectrophotometer.
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3.5.2.3 Direct labelling
Labelling by nick translation
The labelling reaction was set up as follows:
Table 2: Reagent volumes for the labelling reaction.
REAGENT VOLUME (µl) ×1
Nick translation buffer (Appendix A) 10
0.1 M β-mercaptoethanol  (Sigma-aldrich) 10
dNTP mix (Appendix A) 8
DNA 1-2 µg
DNA polymerase I (Promega) 3
DNase I (Roche) dilution¹ ²  1
dH2O Up to 100
TOTAL 100
¹The DNase I dilution used for the p82H probe was 5.5 µl stock in 1ml distilled water
²The DNase I dilution used for the synthetic probe was 0.5 µl stock in 1ml distilled water.
The reaction took place at 15 °C for 30 minutes with regards to the synthetic 
probe, or for two hours for the p82H probe. 
8  μl  of  the  reaction  was  denatured  at  96  °C  for  three  minutes  in  a 
thermocycler  and  electrophoresed  against  a  100  bp  DNA  ladder 
(Fermentas).  The  reaction  was  successful  when  the  DNA  smear  was 
between 200 bp – 500 bp (Figures 17 and 19, Appendix B). If the reaction 
was unsuccessful, one microlitre of the DNase I dilution was added to the 
remainder of the reaction and the reaction was executed at  15 °C for 45 
minutes,  in  the  case  of  the  p82H probe.  Rarely  did  the  synthetic  probe 
require  to  be  redigested,  but  when  it  was  necessary  the  reaction  was 
redigested for 10 – 15 minutes.
Enzymatic Inactivation
The  reaction  was  stopped  by  inactivating  the  enzyme.  This  was 
accomplished  by  adding  3  μl  of  0.5  M EDTA and  1  μl  10  % Sodium 
Dodecyl Sulphate (SDS). The tubes were placed at 65 °C for fifteen minutes 
in a thermocycler.
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Probe precipitation
2 μl of 10 mg/ml herring sperm DNA (Promega),  which binds repetitive 
DNA, was added to the reaction. 3 M NaAc3 was added to the reaction in 
the volume of 10 % of the total volume, and ice-cold 100 % ethanol was 
added at 2.5 × the total volume. The probe was placed at −70 °C overnight. 
The following day the probe was centrifuged at 13000 rpm for 30 minutes at 
4 °C. The supernatant was discarded and 200 µl of ice-cold 70 % ethanol 
was added. It was centrifuged at 13000 rpm for 10 minutes at 4 °C. The 
supernatant  was  discarded  and  the  pellet  was  briefly  air-dried.  Sixty 
microlitres of hybridisation buffer were added to the pellet, which was left 
to dissolve overnight at room temperature.
3.5.3 Hybridisation
Slides were denatured in denaturing solution (Appendix A) heated to 76 °C 
for five minutes, then dehydrated in an ice-cold ethanol series (70 %, 90 % 
and 100 %) for five minutes each. The probe was denatured at 76 °C for five 
minutes,  and put on ice. 7.5 μl of the probe was applied to a coverslip, 
cleaned in 100 % ethanol and with a soft tissue. Each slide was placed on 
the coverslip, and sealed with rubber cement (Fixogum, Marabu). The slides 
were then incubated at 37 °C in a moist chamber overnight.
STARFISH  ©   commercial pan-centromeric probe hybridisation (as per  
protocol)
Slides  were denatured in  70 % formamide /  2  × SSC at  70 °C for  two 
minutes, then placed in ice-cold 70 % ethanol for five minutes followed by 
ice-cold 90 % and ice-cold 100 % ethanol for five minutes each. The probe 
was  denatured  at  85  °C  for  ten  minutes,  and  then  placed  on  ice.  Ten 
microlitres of the commercial probe was added to each slide, sealed with a 
coverslip and rubber cement. The slides were then incubated at 37 °C for 
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about 16 hours in a moist chamber.
3.5.4 Washing
The rubber cement was carefully removed from the slides, which were then 
rinsed in 50 % formamide allowing the coverslip to slip off (or the coverslip 
was gently tapped off) each slide. The slides were washed three times in 50 
% formamide heated to 46 °C for ten minutes each, followed by a 10-minute 
wash in 2 × SSC heated to 46 °C and a five minute wash in 2 × SSC with 
0.1 % Tween heated to 46 °C. The slides were removed from the solutions, 
and mounted with Vectashield containing DAPI, which would counterstain 
the nuclei (blue) by intercalating with the DNA. 
When  Vectashield  with  DAPI  was  not  available,  the  slides  were 
counterstained in a 2 × SSC solution containing 0.2 µg/ml DAPI (Merck) 
for fifteen minutes at room temperature, followed by a two minute wash in 2 
× SSC with 0.1 % Tween. The slides were then mounted with Vectashield.
STARFISH© commercial  pan-centromeric  probe  washing  (as  per 
protocol)
The rubber cement was removed, and the slides rinsed for 5 minutes at 37 
°C in 2 × SSC. The coverslips were then removed. The slides were washed 
twice in 50 % formamide /  2 × SSC for 5 minutes each at  37 °C, then 
washed twice in 2 × SSC for 5 minutes each, and then counterstained and 
mounted with Vectashield with DAPI.
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3.6 Scoring
Slides  were  scored  microscopically,  based  on  distinct  criteria  described 
below. Slides could be scored manually or automatically on the MetaFer 
system. 
3.6.1 Manual scoring
Scoring criteria
Distinct criteria were laid down for scoring the micronuclei (Fenech, 2000). 
Nuclei were scored if they had undergone a single nuclear division i.e. a 
binucleated  cell.  Nuclei  were  approximately of  the  same  size,  and  were 
distinct from one another. Micronuclei were similar in shape to the main 
nuclei with similar staining. The micronuclei ranged in size from 1/16 to 1/3 
of the size of the main nuclei. 
a)  Acridine Orange stained slides  
Nuclei  were  stained  green/yellow  with  a  clear  orange  cytoplasm  with 
acridine orange. Slides were scored under the DAPI filter on 100 × objective 
(oil immersion) on an Olympus BX41 microscope. At least 500 binucleated 
cells were scored per slide (Fenech, 2000).
b)   FISH stained slides 
Metaphase and micronucleus slides were observed under 100 × objective 
(oil immersion) on an Olympus BX61 microscope. A triple filter was used to 
observe  if  the  pan-centromeric  probe  had  bound.  In  the  case  of  the 
metaphase slides, metaphases were observed for the pan-centromeric probe 
binding  onto  all  chromosomes.  Images  were  taken  and  processed  using 
CytoVision. With regards to the micronucleus slides, cells were scored if 
signals were clearly present in the main nuclei. 
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3.6.2 Automated and Semi-automated scoring
Micronuclei were automatically scored with the automated slide scanning 
system,  Metafer.  The  system is  comprised  of  a  computer  containing  the 
appropriate software, a motorised microscope (Axioplan 2 Imaging E MOT 
(Carl  Zeiss))  with  motorised  scanning  stage  (Marzhauser)  and  a  camera 
attached  for  image  acquisition.  The  slide  is  scanned  by  moving  it  in  a 
pattern in reference to a fixed objective lens of a microscope. The field is 
scanned for any objects of interest (in this case, binucleated cells). If any 
objects are found, they are analysed and images are taken and stored in a 
gallery.  The  image  gallery can  be  viewed later  to  review and correct  if 
necessary (Schunck et al, 2004).
a) Automated scoring
Metafer MicroNuclei is the system for detecting micronuclei. The system 
finds binucleated cells stained with a single nuclear stain (e.g. DAPI) under 
fluorescence (it can also be performed with other nuclear or cytoplasmic 
stains  and with  transmitted  light).  Images  are  taken  of  binucleated  cells 
fulfilling the criteria and scored for the presence or absence of micronuclei 
(Schunck et al, 2004). The micronucleus slides were scored automatically 
under  a  10  ×  objective  using  the  DAPI  filter  based  on  the  following 
MSearch classifier settings (Willems et al, 2010): 
Table 3: Classifier setting for the MetaFer, MSearch program.
 
Classifier for the 
binucleated cells 
Classifier for the 
micronuclei
Object threshold (%) 15 7
Minimum area (µm2) 80 1.00
Maximum area (µm2) 1000.00 40.00
Maximum relative concavity depth 0.160 0.700
Maximum aspect ratio 1.370 1.700
Maximum distance (µm) 25 25
Maximum area asymmetry (%) 80
Region of Interest radius (µm) 30
Maximum object area in region of 
interest (µm2)
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The object threshold separates objects from the background. If the object is 
accepted as such it is analysed for various features as follows. The minimum 
and maximum area defines how small or large an object can be for it to be 
accepted as a  nucleus  or  micronucleus.  The  maximum relative concavity  
depth defines  how concave  a  nucleus  or  micronucleus  can  be.  Both  are 
convex having only small concave areas. The specified limit is relative to 
the nucleus  or  micronucleus  diameter  respectively.  The  maximum aspect  
ratio discriminates  round objects  from elongated ones  by comparing  the 
axes with one another. The maximum distance limits how far two nuclei can 
be from one another to be accepted as being part of the same cell (distances 
from the respective centres); it also limits how far a micronucleus can be 
from the centre of the region of interest (R.o.I.) to be included in the cell. 
The  maximum area asymmetry regulates how different in size two nuclei 
can be from one another, thereby rejecting nuclei of neighbouring cells that 
lie  close  together.  The  region  of  interest  (R.o.I.)  radius defines  the  area 
around the two nuclei that is scanned for other objects. Its centre lies in the 
middle of a connecting line between the centres of the nuclei. The maximum 
object area in R.o.I. defines how large an object in the R.o.I. can be before 
the cell is rejected. Therefore cells with more than two nuclei within the 
R.o.I. can be rejected (Schunck et al, 2004; MetaFer manual, 2005). 
Images were taken of the binucleated cells. MSearch was executed with a 
sensitivity of 90 % (9 out of 10), over a search window of 90 % of the slide 
(from the centre of the slide) and scored 1000 to 2000 binucleated cells.
b) Semi-automated scoring
The binucleated cells were reviewed in the image gallery. Only binucleated 
cells having micronuclei were selected from those found in MSearch. These 
cells were scanned again under the AutoCapt programme, with a DAPI filter 
and Spectrum Orange filter and using the 40 × objective. Images were taken 
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of these cells. The images were scored for centromere positive and negative 
micronuclei. Centromere positive micronuclei were scored as such when the 
signal was clear and comparable to those in the nuclei.
3.7 Statistical analysis
GraphPad Prism 4 was used for the analysis of the data, using the Wilcoxon 
signed rank test and the Mann-Whitney test. Confidence intervals were set 
at 95 % for both tests.
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CHAPTER FOUR – RESULTS
4.1 Probe optimisation
The preparation of the pan-centromeric probes needed to be optimised. The 
methods were adjusted in several ways, which are described below for both 
the p82H probe and the synthetic probe.
4.1.1 p82H probe
Bacterial culture
Different amounts of starter cultures were used, including 2 ml, 5 ml and 10 
ml, and a 5 ml starter culture was found to provide optimal growth. The 
starter cultures were diluted in larger amounts, and it was found that 200 ml 
gave sufficient growth for greatest extraction and yield. 
Plasmid extraction 
Throughout the plasmid extraction, samples were taken at different stages 
i.e.  from the filtrate of the Buffers P1, P2 and P3, from the flow-through of 
Buffer QBT, from the filtrate after the washes with Buffer QC, and from the 
eluate (after Buffer QF). The different steps of the extraction were checked 
to  ensure  no  DNA was  being  lost  during  the  extraction  by  means  of 
electrophoresis  on  a  2  % agarose  gel,  and  no DNA was lost  during  the 
extraction. In order to see if increasing the amounts of Buffers P1, P2 and 
P3 enhanced the amount of DNA yield, 8 ml and 10 ml of the Buffers were 
used instead of 4 ml. No difference was seen with the increased amounts 
compared with the 4 ml amount,  and extractions continued with the 4ml 
amount as per protocol. The time involving the steps where Buffers P1, P2 
and P3 were added was monitored carefully. As a lot of chromosomal DNA 
was  still  seen  after  electrophoresis  (Figure  16),  the  lysis  step  involving 
Buffer  P2 was  shortened to  4  minutes  in  order  to  prevent  chromosomal 
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DNA from being lysed, but it made no difference. The kit extraction was 
compared with a manual extraction. The latter resulted in a low yield with 
lots of contamination. p82H was extracted alongside another control BAC 
that  was  known  to  work  in  our  laboratory  with  the  Qiagen  kit.  The 
extractions were comparable.
Labelling by nick translation
Different DNase I dilutions were tried. All were diluted in 1 ml sterile water. 
They were 0.8 μl, 1.0μl, 1.6 μl, 1.9 μl, 2.0 μl, 2.1 μl, 2.5 μl, 3.0 μl, 4.0 μl, 
5.0 μl, 5.2 μl, 5.5 μl. Only the dilution 5.5 μl in 1 ml, digested the DNA  to 
the correct size (Figure 17). The digestion often had to be redigested for 40 
minutes with another 1 μl of the DNase I dilution added to the reaction. 
Different  DNA polymerase amounts  were  used,  3  μl,  4.5  μl,  or  6  μl,  to 
ensure the SpectrumOrange was being added. However, no difference was 
seen between them. p82H was labelled alongside another  BAC that  was 
known to work in our laboratory. Both p82H and the BAC were considered 
successful  after  electrophoresis,  but  where  the  BAC  probe  successfully 
hybridised to a metaphase slide, the p82H probe did not.
4.1.2 Synthetic probe
DNA extractions
Extractions on the whole blood and buffy coat of a sample were performed 
using the Flexigene DNA kit (Qiagen). The yield of the DNA was compared 
with that achieved from the in-house phenol chloroform method, and the in-
house phenol chloroform method resulted in a much greater yield. Different 
EL buffers were used in the in-house phenol chloroform method, EL buffer 
(Qiagen) and Red cell lysis buffer (Roche). The greatest yield was observed 
with the Red cell lysis buffer (Roche).
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PCR
20  μl reactions were originally used instead of 100 μl reactions.  Different 
annealing temperatures were tried, 45 ºC, 49 ºC, 50 ºC, 51 ºC, 52 ºC, 53 ºC, 
51.8 ºC, 52.7 ºC, 55 ºC, 56 ºC, 57 ºC, 58 ºC, 59 ºC, 60 ºC, to determine 
whether  they  would  improve  the  concentration.  It  was  found  that  the 
original programme (see 3.5.2.2) gave the best results.
PCR purification
The  BioSpin  kit  required  two  samples  to  be  pooled  in  order  to  get  a 
sufficient yield. Sterile water was used to dissolve the PCR product, instead 
of the provided elution buffer.
Different elution amounts were tried for the Roche kit. The PCR product 
was eluted with 50 μl only or in two steps with 50 μl each, where the second 
50 μl was added to the filter tip once the first had been centrifuged through 
it. The greatest yield was achieved with the single 50 μl elution step.
Labelling by nick translation
The incubation time was shortened to 30 minutes, and 0.5 μl DNase I stock 
diluted in 1 ml sterile water digested the DNA to the correct size.  When 
required, the reaction was redigested for 15 minutes.
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4.2 FISH
The FISH methodologies needed to be optimised in order to achieve the best 
results, i.e. clear strong signals with little background. The pan-centromeric 
probes were applied to metaphase chromosomes by means of FISH, in order 
to test whether the probes were able to hybridise to the centromeres of all 
chromosomes. The p82H probe never hybridised to any centromeres on any 
slide,  whereas  the  synthetic  probe  did  hybridise  successfully  to  all  the 
centromeres and clear signals could be observed. Hereafter, the term pan-
centromeric probe refers to the synthetic probe.  The synthetic probe was 
comparable with the commercial STARFISH© pan-centromeric probe.
4.2.1 FISH optimisation
Various pretreatments were tried, including a RNase only pretreatment, two 
different  RNase  and  pepsin  pretreatments  (I  and  II),  a  pepsin  only 
pretreatment, and slides that remained untreated were used as controls, in 
order to lower background and optimise the FISH. To determine how long 
the  pepsin  treatment  should  be  in  RNase  and  pepsin  pretreatment  II, 
micronucleus  slides  were  incubated  for  5  minutes,  7.5  minutes  and  10 
minutes or not treated at all. The slides were stained with acridine orange, 
and  observed  under  a  microscope.  The  desired  result  was  to  have  no 
cytoplasm, which was achieved after 5 minutes. The various pretreatments 
had little effect on lowering the background and were therefore abandoned.
Changes were made to the FISH protocol in order to lower background. The 
wash solutions, which are usually heated to 46 °C, were heated to 47 °C - 48 
°C. This did lower the background,  and subsequently the solutions  were 
heated at these temperatures in this study.
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4.2.2 Classic cytogenetic test
The  pan-centromeric  probe  was  hybridized  to  metaphase  chromosomes 
(Figure  8).  Figure  8  shows  that  the  synthetic  pan-centromeric  probe 
hybridized to the centromeres of all 46 chromosomes, indicating successful 
probe preparation and labelling.  Another  metaphase slide was hybridised 
with the commercial  STARFISH© pan-centromeric probe. The two probes 
were  comparable  with  one  another,  both  in  hybridising  to  all  of  the 
chromosomes and in signal strength.
Figure  8:  DAPI  stained  metaphase  chromosomes  (blue)  showing  the 
synthetic  pan-centromeric  probe  (red  signals)  hybridising  to  all  46 
chromosomes
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4.2.3 Micronucleus assay
The  pan-centromeric  probe  was  hybridized  to  micronucleus  slide 
preparations (Figure 9). Figure 9A shows a binucleated cell with a single 
micronucleus containing 3 signals. This indicates that the micronucleus was 
centromere-positive, and assumed to be a result of aneugenic events i.e. the 
loss of whole chromosomes due to chromosome lagging etc. The signal may 
be a separate chromosome or chromatid expelled from the cell. In this study, 
the centromere-positive cells were considered to be a result of spontaneous 
damage.  Figure  9B shows a  binucleated  cell  with  a  single  micronucleus 
without  any  signals.  The  pan-centromeric  probe  hybridised  to  the 
centromeres in the main nuclei therefore the lack of signal was not because 
of  poor  hybridisation.  Centromere-negative  cells  arise  as  a  result  of 
clastogenic events, where chromosomal fragments are lost from the cell due 
to the action of a clastogen, in this case, radiation.
Figure  9:  DAPI  stained  binucleated  cells  hybridised  with  the  pan-
centromeric probe with a single micronucleus with (A) or without a signal 
(B). A) DAPI-stained binucleated cell with a single micronucleus exhibiting 
a signal (white arrow), within the micronucleus. Therefore the micronucleus 
is  centromere-positive.  B)  DAPI-stained  binucleated  cell  with  a  single 
micronucleus  showing  no  signals  (green  arrow).  The  micronucleus  is, 
therefore,  centromeric-negative.  Note  that  the  pan-centromeric  probe  has 
bound to  the  centromeres  within  the  main nuclei  (black arrows)  thereby 
acting as a control to ensure FISH was successful.
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4.3 Dose-response study
All  of  the  blood  samples  collected  were  from  women,  and  none  were 
smokers. The samples were also age-matched.
4.3.1 Automated versus semi-automated scoring
Scoring  completely  automatically  was  compared  with  scoring  semi-
automatically  with  the  Wilcoxon  signed  rank  test.  The  results  of  this 
comparison  are  shown  in  Figure  10,  with  the  standard  deviation.  A 
significant difference (p < 0.05) was found between the two. Note, also, that 
the semi-automated scoring follows a  linear  quadratic  form,  whereas  the 
automated scoring does not in the area of the low doses (0 Gy – 0.5 Gy). 
The slides were scored under a single filter, i.e. DAPI, where the automated 
scoring includes everything that the MetaFer scored as a binucleated cell 
containing micronuclei, and the semi-automated scoring includes only true 
binucleated cells with true micronuclei, false positives were excluded by the 
scorer. Consequently, scoring was performed semi-automatically for further 
studies.
Figure 10: The total  number of micronuclei  scored completely automatically or 
semi-automatically (standard deviation indicated by error bars). 
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4.3.2 Dose response curves
The samples were scored for micronuclei on the automated MetaFer system 
semi-automatically with a dual filter (DAPI and SpectrumOrange). The total 
number of micronuclei scored semi-automatically is plotted in Figure 11, 
with Figure 11A showing all doses and Figure 11B showing the low doses. 
Figure  12  shows  these  micronuclei  classified  as  centromere-positive  or 
centromere-negative based on whether or not a pan-centromeric signal was 
present. The percentage of centromere-negative micronuclei was plotted in 
Figure 13. The dose response curves are linear quadratic curves. 
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Figure 11:  The averages of total number of micronuclei scored, arising as a 
result of exposure to different doses of gamma radiation (standard deviation 
indicated by error bars). Figure 11A shows results for doses 0 Gy to 2 Gy, 
while Figure 11B shows results for the low doses (0 Gy to 0.5 Gy).
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Figure  12:  The  averages  of  total  micronuclei  (Total  MN),  centromere-
positive micronuclei (CM+MN) and centromere-negative micronuclei (CM-
MN) at  all  doses (Figure 12A) and at  low doses (Figure 12B).  Standard 
deviation indicated by error bars.
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Figure 13: The percentages of centromere-negative micronuclei  scored at 
different  doses  of  gamma  radiation  (standard  deviation  indicated  by  the 
error bars). Figure 13A shows results for the doses, 0 Gy to 2 Gy, and Figure 
13B shows results for the low doses (0 Gy to 0.5 Gy).
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Table 4: Significant differences in the total number of micronuclei and 
the percentage of centromere-negative micronuclei between doses using 
the Wilcoxon signed rank test 
Dose (Gy)
Significant difference in 
micronucleus counts (95 
% Confidence Intervals)
Significant difference in 
percentage centromere- 
negative micronuclei (95 
% Confidence Intervals)
0 – 0.05 * (p = 0.0488) * (p = 0.0273)
0.05 – 0.1 × * (p = 0.0020)
0.1 – 0.2 * (p = 0.0059) ×
0.2 – 0.3 × * (p = 0.0039)
0.3 – 0.5 * (p = 0.0020) * (p = 0.0137)
0.5 – 0.75 × ×
0.75 – 1 × ×
1 – 2 × ×
* indicates  a  statistically  significant  difference  was  found  between  the  
doses. 
× indicates no statistically significant difference was found.
The  pan-centromeric  marker  combined  with  the  micronucleus  assay  can 
accurately  differentiate  between  spontaneous  (CM+MN)  and  radiation-
induced  micronuclei  (CM-MN).  Significant  differences  were  observed 
(Table 4) based on total  micronucleus counts and percentage of CM-MN 
between low doses, which confirms previous work (Pala et al, 2008; Vral et 
al, 1997); significant differences were observed with a dose as low as 0.05 
Gy, which has not been previously reported. 
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4.4 HIV study
The HIV+ samples and controls  were age-matched and sex-matched,  the 
majority were women and non-smokers.  The first  part  of  the HIV study 
involved micronucleus assays performed on blood samples collected from 
19 HIV+ patients and 13 HIV- controls. The blood cultures were exposed to 
2  Gy and  4  Gy doses  of  X-irradiation,  and  control  blood cultures  were 
mock-irradiated. These samples were scored manually for micronuclei, as 
shown  in  Figure  14.  The  data  collected  was  analysed  using  the  Mann-
Whitney Test with confidence intervals set at 95 %. A p-value > 0.05 was 
found, therefore no significant difference was observed between the HIV+ 
and HIV- samples at any dose. 
Figure 14: The average number of total micronuclei of HIV+ versus that of 
HIV-  samples  exposed  to  doses  of  0  Gy,  2  Gy  and  4  Gy  X-radiation 
(standard deviation indicated by error bars).
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In the second part of the HIV study, eight HIV+ and four HIV- samples were 
not irradiated and were analysed semi-automatically on the MetaFer system. 
This was done because no significant differences were found between the 
total micronucleus counts of HIV+ and HIV- samples (Figure 14) according 
to the Mann-Whitney test (p > 0.05), and these results were unexpected, as 
data collected in a previous study indicated a significant difference between 
HIV+ and HIV- chromosomal sensitivity (Baeyens et al, 2010). The slides 
from  the  unexposed  samples  were  hybridised  with  the  pan-centromeric 
probe (Figure 15) and were scored semi-automatically on the MetaFer, and 
analysed  with  the  Mann-Whitney test.  Although there  are  no  significant 
differences  in the total  number of micronuclei  found between HIV+ and 
HIV- individuals, a slightly higher number of total micronuclei in the HIV+ 
individuals was noticed, which was attributed to the number of CM+MN.
Figure  15:   The  number  of  total  micronuclei  (Total  MN),  centromere-
positive (CM+MN) and centromere-negative micronuclei (CM-MN), from 
unexposed HIV+ and HIV- samples (standard deviation indicated by error 
bars).
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CHAPTER FIVE – DISCUSSION
This study aimed to develop a pan-centromeric probe, and optimise it for 
use in cases of radiation exposure, and possibly for routine biomonitoring of 
radiation workers. In order to accomplish this, two different methods for the 
preparation of the pan-centromeric probe were tried, the p82H probe and the 
synthetic pan-centromeric probe. The probe was applied to cells that were 
exposed  to  various  doses  of  gamma  radiation,  and  the  damage  was 
examined. From the amount of micronuclei, dose response curves could be 
set up. Lastly, the chromosomal radiosensitivity of HIV-infected individuals 
was explored.
Only  the  synthetic  pan-centromeric  probe  successfully  labelled  the 
centromeres.  The  plasmid,  p82H,  was  successfully  extracted  (Figure  16, 
Appendix  B)  and  labelled  by  means  of  nick  translation  (Figure  17, 
Appendix B), but failed to bind to the  centromeres of any chromosome. It 
was  speculated  that  the  plasmid  had lost  the  p82H insert.  The  synthetic 
probe  was isolated  from extracted  human male  DNA through PCR with 
specified primers (Figure 18, Appendix B), and labelled by means of nick 
translation (Figure 19, Appendix B). A possible improvement to this method 
may be to label the synthetic probe during PCR. Backx et al (2008) showed 
that  labelling  Bacterial  Artificial  Chromosomes  (BAC)  clones  during 
Degenerative Oligonucleotide Primed (DOP)-PCR resulted in strong FISH 
signals with minimal background as compared with the clones that were 
labelled  by  means  of  traditional  methods.  The  thermobrite  (Abbott 
Molecular), is a machine, which uses temperature to denature the DNA and 
hybridise  the  probe  to  a  slide.  It  would  reduce  time  by  eliminating  the 
denaturing step of the manual FISH procedure.
For the dose response study, the samples were exposed to gamma radiation 
from a Cobalt-60 source. Gamma radiation is highly energetic and a highly 
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penetrative form of electromagnetic radiation. It is often used as a standard 
in  radiation  studies,  and  other  radiation  types  are  compared  with  it.  X-
radiation  was  used  in  the  HIV study.  It  is  also  a  highly  energetic  and 
penetrative form of radiation, and is very similar to gamma radiation. 
The micronucleus assay is a valuable, thoroughly validated and standardised 
technique that can be used to evaluate radiation exposure of occupationally, 
medically  and  accidentally  exposed  individuals,  and  to  assess  in  vitro 
radiosensitivity. The scoring of micronuclei is simple, quick and does not 
require specific experience in cytogenetics. No special equipment is needed 
and the cost is low. However, one drawback is that it is not sensitive enough 
to distinguish between exposures to low doses of ionising radiation.  The 
restricted sensitivity of the micronucleus assay is  because of the relative 
high  and  variable  spontaneous  micronucleus  yield.  The  most  important 
factors influencing this  background are age and sex (Fenech et  al,  1994; 
Thierens et al, 1996). Detection of centromeres showed that the age increase 
of background micronuclei can be attributed almost totally to centromere-
positive  micronuclei,  reflecting  an  increased  chromosome loss  with  age. 
This  restricted  sensitivity  is  a  problem as  most  exposures  occur  at  low 
doses.  Combining  the  micronucleus  assay  with  FISH  using  a  pan-
centromeric probe greatly enhances the sensitivity of the test allowing the 
distinction  of  and  between ionising  radiation  doses,  especially  important 
among  the  very  low  dose  range  (0.05  Gy,  0.1  Gy,  0.2  Gy).  The  pan-
centromeric  probe  allowed  the  distinction  between  centromere-positive 
(spontaneous)  micronuclei,  and  centromere-negative  micronuclei,  which 
arose  as  a  result  of  exposure  to  damaging  agents,  in  this  case  ionising 
radiation. Several studies have validated (Wojcik et al, 2000) and used the 
micronucleus-centromere assay  in cytogenetic studies and biomonitoring 
projects (Thierens et al, 1999; Sari-Minodier et al, 2002; Bolognesi et al, 
2004) that involved radiation or exposure to other clastogenic agents. These 
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studies found that the micronucleus-centromere assay was more sensitive 
than  the  normal  micronucleus  assay,  and  that  the  total  micronucleus 
frequency was higher  in  exposed groups and the amount  of  centromere-
negative micronuclei was also higher in exposed groups.
The results of the study corroborate those found previously by Vral et al 
(1997), where the damages induced, i.e. amount of micronuclei, and among 
these, the amount of centromere-negative micronuclei,  by the same doses 
are similar. In this study, a statistically significant difference could be seen 
with a dose as low as 0.05 Gy compared with the unirradiated sample both 
in  the  micronuclei  count  and  in  the  percentage  increase  of  centromere-
negative micronuclei.  The percentage of centromere-negative micronuclei, 
which may arise because of exposure to ionising radiation, can therefore 
help with evaluating the initial exposure dose. This is important when no 
significant  difference  is  found  between  the  total  micronuclei  counts  of 
different  doses,  as  in  the  case  between  0.05  Gy  and  0.1  Gy,  where  a 
statistically  significant  difference  could  be  seen  in  the  percentage  of 
centromere-negative micronuclei. Similarly this was observed between 0.2 
Gy and 0.3 Gy. Future studies may focus on investigating whether the test 
could be used in extremely low dose exposures, i.e. doses below 0.05 Gy. 
The  dose-response  curve,  therefore,  showed  that  the  micronucleus-
centromere  assay  adds  a  significant  improvement  for  an  effective 
biomonitoring methodology.
Although the LNT model is followed, some studies have indicated that low 
doses of radiation can be beneficial, as is the case of the adaptive response 
in radiation, which showed that exposure to a low dose of radiation could 
partially protect against a larger dose (Wolff, 1998). It was hypothesised that 
the low dose exposure activated a repair mechanism, which was active when 
the larger dose was applied, and could repair some of the damage induced. 
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However,  this  adaptive  response  depended  on  several  factors,  such  as  a 
minimal  dose  before  it  can  become  active,  dose  rate,  individual 
radiosensitivity, and the magnitude of the dose. Newer work has explored 
the presence and/or lack of mRNAs, and changes in gene transcription that 
resulted from irradiation (Wolff, 1998). 
The automation of the micronucleus-centromere assay greatly improves the 
test for use over manual scoring (Schunck et al, 2004, Varga et al, 2004; 
Willems et  al,  2010). It reduces the turnover time of the test,  allows for 
high-throughput,  which  is  important  with  regards  to  large  radiation 
accidents or for biomonitoring projects where large populations need to be 
tested. 
There is a great variation regarding chromosomal radiosensitivity, which is 
affected by smoking habits, age (increases with age), gender (females have 
greater  radiosensitivity),  and  even  physiological  conditions  (such  as 
pregnancy) (Bonassi et al, 2003;  Fenech et al, 1994;   Fenech, 1998; Ricoul 
et  al,  1997; Thierens et  al,  1996).  It has been observed clinically and in 
previous  published  data  that  HIV+  individuals  exhibit  a  greater 
radiosensitivity to ionising radiation than uninfected individuals,  and that 
this difference is statistically significant (Baeyens et al, 2010). This raises a 
few concerns regarding the treatment for cancer patients that are HIV+, and 
the  protection  of  HIV+  radiation  workers.  It  is,  therefore,  important  to 
explore this further to ensure optimal treatment and sufficient protection.  
The regulations regarding radiation protection do not completely take into 
account  an  individual's  response  to  radiation,  and  their  variation  in 
radiosensitivity.  Low  doses  that  are  considered  “safe”  by  protection 
standards may not be so in an individual,  if  they are unable to detect  or 
repair  the  damage.  These  individuals  would  be  at  increased  risk  in  any 
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environment involving radiation. Schnarr et al (2007) found large variation 
between individuals and in different cellular populations. They found that 
the  largest  variation  was  observed  in  the  CD4+  T-cell  sub-population 
compared with CD8+ T-cell and total lymphocyte populations.  Moreover, 
they  also  found  that  with  increasing  age,  the  lymphocytes  became  less 
sensitive to radiation. 
Different  sub-populations  of  T-cells  have  different  susceptibilities  to 
ionising radiation. Wilkins et al (2002) explored this in their study when 
they isolated different sub-populations of white blood cells and exposed the 
isolated sub-populations to low doses of X-rays. They observed that CD4+ 
T-cells and CD8+ T-cells were the most radiosensitive, and CD8+ T-cells 
were more sensitive than CD4+ T-cells based on their apoptotic fractions. 
Co60-radiation has been shown to induce more micronuclei  in  CD4+ T-
cells, compared with CD8+ T-cells (Holmen et al, 1994), but other types of 
radiation  have  been  shown to induce  more  micronuclei  in  CD8+ T-cells 
(Wuttke et al, 1993). Both studies used the same assay. CD4+ T-cells were 
found by Stern et al (1994) to have a greater sensitivity to the genotoxic 
effects of the antiretroviral (ARV) drug, 3-azido-3-deoxythymidine (AZT) 
compared with CD8+ T-cells. In their review, Weng and Morimoto (2009), 
noted that CD4+ T-cells  appeared to be less sensitive than CD8+ T-cells 
when activated, but more sensitive when not activated, and that CD4+ T-
cells have higher micronuclei counts in response to mutagens as compared 
with CD8+ T-cells.  It has also been observed that HIV+ patients display 
compromised normal  tissue tolerance during radiotherapy.  Data collected 
from  HIV+  patients  and  uninfected  controls  shows  that  micronucleus 
frequencies are consistently higher in HIV+ patients (Baeyens et al, 2010).
Despite previous published data (Baeyens et al, 2010), this study has found 
no  significant  differences  between  HIV+  individuals  and  an  uninfected 
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group (Figure 14). Many samples had to be excluded because too few cells 
were  obtained  for  accurate  analysis.  The  previous  published  data  where 
HIV+ were more radiosensitive than HIV- individuals did raise the question 
whether  this  higher  sensitivity  to  radiation  is  caused  by  chromosomal 
instability.  A  higher  chromosomal  instability  would  result  in  a  higher 
CM+MN count, which was seen in this study. 
There  are  certain  difficulties  in  applying the micronucleus  assay to  HIV 
infected  people,  already  low  CD4  counts  below  200  cells/mm3  were 
excluded from the study as previous data found too few cells for appropriate 
analysis, and infected people treated with HAART were also excluded as the 
treatments  might  have  interfered  with  the  results  of  the  assay.  The  HIV 
infected samples produced fewer viable cells in the assay resulting in lower 
yields compared with uninfected controls. This poor proliferative response 
has  been  observed  previously,  as  well  as  cell  death  after  lymphocyte 
stimulation, in HIV+ populations. Medina et al (1994) noted that no matter 
what mitogen was used to stimulate the lymphocytes to divide, a number of 
the lymphocytes from the HIV+ sample died prematurely. It was also noted 
that stronger mitogens, such as PHA, exert a greater effect i.e. more cells die 
prematurely,  which may be because lymphocytes respond faster  to PHA. 
They  attributed  this  loss  to  Activation-Associated  Lymphocyte  Death 
(AALD). It was observed that AALD affected the different sub-populations 
differently. In general, it occurred in CD8+ T-cells more than CD4+ T-cells, 
but it was found it occurred in greatest frequency in memory CD4+ T-cells 
of  HIV+ individuals  in  their  study (Medina  et  al,  1994).  Furthermore,  a 
large variation among individuals CD4+ T-cells sub-populations was found 
(Schnarr et al, 2007).
HIV  was  previously  reported  to  be  relatively  resistant  to  X-irradiation 
(Henderson et al, 1992), and its reverse transcriptase has the ability to read 
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through damaged bases. But this study was performed on the virus alone 
and not in infected cells. In HIV infected cells, Sun et al (2006) found that 
radiosensitivity  increased  in  Tat-expressing  cells  and  that  the  cells  were 
unable  to repair  many radiation-induced DNA DSBs. Many cycle-related 
genes, such as DNA-PKCS,  Cdc20,Cdc25C, KIF2C, CTS1, were also down-
regulated. They suggested that HIV Tat was responsible for the enhanced 
radiosensitivity, because it hindered repair and cell-cycle checkpoints. HIV 
Tat does impair telomerase in infected lymphocytes (Franzese et al, 2004), 
and it is involved in gene expression (Freed, 2001) 
Accessory HIV proteins, like Viral Protein R (Vpr), may also play a role. 
Vpr has a number of effects on the infected cell and is involved in many 
processes,  including  reverse  transcription,  nuclear  import,  cell  cycle 
progression,  regulation  of  apoptosis,  gene  expression  (Le  Rouzic  and 
Benichou,  2005).  Vpr recruits  a DNA repair  enzyme,  UNG, to the virus 
particle.  It  can  induce  cell-cycle  arrest  at  the  G2  phase,  just  before 
integration of the viral DNA, and is capable of inducing apoptosis by acting 
on the mitochondria. This Vpr-mediated arrest is different from one caused 
by DNA damage, and allows optimal conditions for the HIV transcription. 
Vpr up- or down-regulates various cell genes. Vpr can rupture the nuclear 
envelope,  which  may cause  DNA damage  such  as  DSBs.  It  has  a  high 
affinity for nucleic acids (Le Rouzic and Benichou, 2005). Overexpression 
of Vpr has  been observed with abnormalities  in  mitosis,  cytokinesis  and 
nuclear structure (Skalka and Katz, 2005). Vpr has also been implicated in 
micronucleus formation and aneuploidy (Shimura et al, 1999a; Shimura et 
al, 1999b)
The integration process,  whereby the virus inserts  its  DNA into the host 
genome,  results  in a complex lesion.  The lesion interrupts the chromatin 
conformation  and  composition.  The  damage  is  repaired  by  specific 
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pathways, but some may escape and lead to DSBs. The infected cells repair 
the  damage  as  they  would  for  radiation-induced  DSBs  because  of  the 
chromatin alteration, the free DNA ends and the integration intermediates, 
which resemble the damage repaired by NHEJ (Skalka and Katz, 2005). The 
PIC  contains  various  proteins,  which  may  be  involved  in  chromatin 
remodelling (Freed, 2004). The chromatin remodelling may leave the DNA 
more  open,  and  therefore  more  susceptible  to  damage  from  ionising 
radiation.
A pan-centromeric  probe  was  developed  and  optimised  for  use  in  the 
micronucleus assay combined with FISH. This assay can be automated on 
the MetaFer system successfully, making the assay faster and adaptable for 
large-scale studies. The dose response study allowed the detection of doses 
of  ionising  radiation  as  low as  0.05  Gy,  and the  pan-centromeric  probe 
showed that even among doses where the total micronucleus counts were 
not significantly different, it was still possible to distinguish between doses 
based on their percentage of centromere-negative micronuclei.  This study 
did  not  show  any  significant  difference  between  HIV+  individuals  and 
uninfected  individuals,  but  showed  a  higher  chromosomal  instability  in 
HIV+ individuals.  Little  is  understood as  to  why HIV+ samples  exhibit 
enhanced radiosensitivity. The micronucleus assay coupled with FISH using 
a pan-centromeric probe proved to be a sensitive tool in this study. It was 
adapted to an automated system, and very low doses of ionising radiation 
could be detected. It could make an effective tool for biomonitoring, and 
greatly aid future studies.
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CHAPTER SIX – CONCLUSIONS 
• The  micronucleus  assay  combined  with  a  pan-centromeric  probe 
greatly enhances the sensitivity of the test allowing the distinction of 
and between ionising radiation doses.
• The  micronucleus-centromere  assay  can  be  automated,  allowing 
high-throughput, which is important regarding large-scale radiation 
accidents and biomonitoring projects. 
• HIV+ samples were not found to be more radiosensitive than HIV- 
samples in this study, contrary to previous published data.
• A higher CM+MN count was observed in the HIV+ samples, which 
suggests a higher chromosomal instability among HIV+ people.
68
REFERENCES
The AIDS 2008 Impact Report. XVII International AIDS Conference.
Aleixandre C, Miller DA, Mitchell AR, Warburton DA, Gersen SL, Disteche 
C, Miller OJ. 1987. p82H identifies sequences at every human centromere. 
Hum. Genet. 77: 46–50.
Angerer J, Ewers U, Wilhelm M. 2007. Human biomonitoring: State of the 
art. International Journal of Hygiene and Environmental Health, 210: 201–
228.
Au  WW.  2007.  Usefulness  of  biomarkers  in  population  studies:  From 
exposure to susceptibility and to prediction of cancer. International Journal 
of Hygiene and Environmental Health, 210: 239–246.
Aukrust P, Luna L, Ueland T, Johansen RF, Muller F, Froland SS, Seeberg 
EC,  Bjoras M. 2005. Impaired base excision repair  and accumulation of 
oxidative base lesions in CD4+ T cells of HIV infected patients. Blood 105: 
4730–4735.
Backx L, Thoelen R, Van Esch H, Vermeesch JR. 2008. Direct fluorescent 
labelling of clones by DOP PCR. Molecular Cytogenetics 1: 3.
Baeyens A. 2005. In Vitro Chromosomal Radiosensitivity in Breast Cancer 
Patients. PHD thesis.
Baeyens  A,  Slabbert  JP,  Willem  P,  Vral  A.  2007.  Radiosensitivity  of 
Lymphocytes in HIV Positive Individuals. SAAPMB Congress.
69
Baeyens A, Slabbert JP, Willem P, Jozela S, van der Merwe D, Vral A. 2010. 
Chromosomal  radiosensitivity  of  HIV  positive  individuals.  International 
Journal of Radiation Biology. In publication.
Bolognesi  C,  Landini  E,  Perrone  E,  Roggieri.  2004.  Cytogenetic 
biomonitoring of a floriculturist population in Italy: micronucleus analysis 
by  fluorescence  in  situ  hybridisation  (FISH)  with  an  all-chromosome 
centromeric probe. Mutation Research 557: 109–117.
Bonassi S, Neri M, Lando C, Ceppi M, Lin Y-P, Chang WP, Holland N, 
Kirsch-Volders M, Zeiger E, Fenech M. 2003. Effect of smoking habit on 
the  frequency  of  micronuclei  in  human  lymphocytes:  results  from  the 
Human MicroNucleus project. Mutation Research 543: 155–166. 
Campbell EM, Hope TJ. 2008. Live cell imaging of the HIV-1 life cycle. 
Trends in Microbiology 16: 580–587.
Christmann  M,  Tomicic  MT,  Roos  WP,  Kaina  B.  2003.  Mechanisms  of 
human DNA repair: an update. Toxicology 193: 3–34.
Darroudi F, Fomina J, Meijers M. 2008. Biological Dosimetry in cases of 
accidental and occupational exposure to ionising radiation: State of the art. 
Radioprotection, 43: 27–31.
Dianiak N, Waselenko JK, Armitage JO, MacVittie TJ, Farese AM. 2003. 
The Hematologist and Radiation Casualties. Hematology 473–496.
Fenech  M,  Morley  AA.  1985.  Measurement  of  micronuclei  in  human 
lymphocytes. Mutat. Res. 148: 29–36.
70
Fenech M, Neville S, Rinaldi J. 1994. Sex is an important variable affecting 
spontaneous micronucleus frequency in cytokinesis-blocked lymphocytes. 
Mutation Research 313: 203–207.
Fenech M. 1998. Important variables that influence base-line micronucleus 
frequency  in  cytokinesis-blocked  lymphocytes  –  a  biomarker  for  DNA 
damage in human populations. Mutation Research 404: 155–165.
Fenech, M. 2000. The in vitro micronucleus technique. Mutation Research 
455: 81–95.
Franzese O, Comandini A, Adamo R, Sgadari C, Ensoli B, Bonmassar E. 
2004. HIV-Tat down-regulates telomerase activity in the nucleus of human 
CD4+ T cells. Cell Death and Differentiation 11: 782–784.
Freed EO. 1998. HIV-1 Gag proteins:  diverse functions in the virus life-
cycle. Virology 251: 1–15.
Freed EO. 2001. HIV-1 Replication. Somatic Cell and Molecular Genetics 
26: 13–33.
Freed EO. 2004. HIV-1 and the host cell: an intimate association. TRENDS 
in Microbiology 12: 170–177.
Galati D, Bocchino M, Paiardini M, Cervasi B, Silvestri G, Piedimonte G. 
2002. Cell  Cycle  Dysregulation During HIV Infection:  Perspectives  of a 
Target  Based  Therapy.  Current  Drug  Targets  –  Immune,  Endocrine  & 
Metabolic Disorders 2: 53–62.
71
Henderson  EE,  Tudor  G,  Yang  J-Y.  1992.  Inactivation  of  the  Human 
Immunodeficiency Virus Type 1 (HIV-1) by Ultraviolet and X Irradiation. 
Radiation Research 131: 169–176.
Hittelman WN, Pandita TK. 1994. Possible role of chromatin alteration in 
radiosensitivity of Ataxia Telangiectasia . Int. J. Radiat. Biol., 66: 109–113.
Hoeijmakers JHJ. 2001. Genome maintenance mechanisms for preventing 
cancer. Nature, 411: 366–374.
Holmen A, Karlsson A, Bratt I, Hogstedt B. 1994. Micronuclei and mitotic 
index in B-, T4- and T8-cells treated with mitomycin-C and  γ-irradiation. 
Mutation Research, 309: 93–99.
Iarmarcovai G, Botta A, Orsièse T. 2006. Number of centromeric signals in 
micronuclei and mechanisms of aneuploidy. Toxicology Letters 166: 1–10.
Jeeninga RE, Westerhout EM, van Gerven ML, Berkhout B. 2008. HIV-1 
latency in actively dividing human T-cell lines. Retrovirology 5: 37
Kanaar R, Hoeijmakers JHJ, Van Gent DC. 1998. Molecular mechanisms of 
DNA double-strand break repair. Trends Cell Biol., 8: 483–489.
Khanna  KK,  Jackson  SP.  2001.  DNA double-strand  breaks:  signalling, 
repair and the cancer connection. Nat. Genet., 27: 247–254.
Le Rouzic E, Benichou S. 2005. The Vpr protein from HIV-1: distinct roles 
along the viral life cycle. Retrovirology 2:11
72
Lindberg HK, Wang X, Järventaus H, Falck GCM, Norppa H, Fenech M. 
2007. Origin of nuclear buds and micronuclei in normal and folate-deprived 
human lymphocytes. Mutation Research 617: 33–45.
Little  JB,  Nagasawa H.  1985.  Effect  of  confluent  holding  on potentially 
lethal damage repair, cell cycle progression and chromosome aberrations in 
human normal and Ataxia Telangiectasia fibroblasts. Radiat. Res., 101: 81–
93. 
Ma Y, Pannicke U,  Schwarz K,  Lieber  MR. 2002. Hairpin Opening and 
Overhang  Processing  by   an  Artemis/DNA-Dependent  Protein  Kinase 
Complex in Nonhomologous End Joining and V(D)J Recombination. Cell 
108: 781–794.
Medina  E,  Borthwick  N,  Johnson  MA,  Miller  S,  Bofill  M.  1994.  Flow 
cytometric  analysis  of  the  stimulatory  response  of  T  cell  subsets  from 
normal and HIV-1+ individuals to various mitogenic stimuli in vitro. Clin. 
Exp. Immunol. 97: 266–272.
MetaFer manual. 2005. MetaSystems. MSearch manual V.3.1: 9 – 11.
Mitchell AR, Gosden JR, Miller DA. 1985. A cloned sequence, p82H, of the 
alphoid  repeated  DNA family  found  at  the  centromeres  of  all  human 
chromosomes. Chromosoma 92: 369–377. 
Pala FS, Alkaya F, Tabakcioglu K, Tokatli F, Uzal C, Parlar S, Algunes C. 
2008.  The  effects  of  micronuclei  with  whole  chromosome on  biological 
dose estimation. Turk. J. Biol. 32: 283–290.
73
Parshad  R,  Sanford  KK,  Jones  GM.  1983.  Chromatid  damage  after  G2 
phase  x-irradiation  of  cells  from  cancer  prone  individuals  implicates 
deficiency in DNA repair. Proc. Natl. Acad. Sci. USA, 80: 5612–5616. 
Pfeiffer P, Goedecke W, Kuhfittig-Kulle S, Obe G. 2004. Pathways of DNA 
double-strand break repair and their impact on the prevention and formation 
of chromosomal aberrations. Cytogenet. Genome Res 104: 7–13.
Preston RJ. 1980. DNA repair and chromosome aberrations: the effect of 
cytosine arabinoside on the frequency of chromosome aberrations induced 
by radiation and chemicals. Teratog. Carcinog. Mutagen, 1: 147–159.
Ricoul  M,  Sabatier  L,  Dutrillaux  B.  1997.  Increased  chromosome 
radiosensitivity during pregnancy.  Mutation Research – Fundamental  and 
Molecular Mechanisms of Mutagenesis 374: 73–78.
Rothkamm K, Lobrich M. 2003. Evidence for a lack of DNA double-strand 
break repair in human cells exposed to very low x-ray doses. PNAS 100: 
5057–5062.
Sanford KK, Parshad R, Gantt R, Tarone RE, Jones GM, Price FM. 1989. 
Factors  affecting  and  significance  of  G2  chromatin  radiosensitivity  in 
predisposition to cancer. Int. J. Radiat. Biol., 55: 963–981. 
Sari-Minodier I, Orsiere T, Bellon L, Pompili J, Sapin C, Botta A. 2002. 
Cytogenetic monitoring of industrial radiographers using the micronucleus 
assay. Mutation Research 521: 37–46.
Schnarr K, Dayes I, Sathya J, Boreham D. 2007. Individual radiosensitivity 
and its relevance to health physics. Dose-Response 5: 333–348.
74
Schunck  C,  Johannes  T,  Varga  D,  Lorch  T,  Plesch  A.  2004.  New 
developments  in  automated  cytogenetic  imaging:  unattended  scoring  of 
dicentric  chromosomes,  micronuclei,  single  cell  gel  electrophoresis,  and 
fluorescence signals. Cytogenetic and Genome Research, 104: 383–389. 
Scott  D,  Barber  JBP,  Spreadborough  AR,  Burrill  W,  Roberts  SA.  1999. 
Increased  chromosomal  radiosensitivity  in  breast  cancer  patients:  a 
comparison of two assays. Int. J. Radiat. Biol., 75: 1–10.
Shimura M, Tanaka Y, Nakamura S, Minemoto Y, Yamashita K, Hatake K, 
Takaku F, Ishizaka Y. 1999a. Micronuclei formation and aneuploidy induced 
by  Vpr,  an  accessory  gene  of  human  immunodeficiency  virus  type  1. 
FAESB Journal 13: 621–637.
Shimura M, Onozuka Y, Yamaguchi  T,  Hatake K, Takaku F,  Ishizaka Y. 
1999b.  Micronuclei  formation  with  chromosome  breaks  and  gene 
amplification  caused  by  Vpr,  an  accessory  gene  of  human 
immunodeficiency virus type 1. Cancer Research 59: 2259–2264.
Singh NP, McCoy MT, Tice RR, Schneider EL. 1988. A simple technique 
for  quantitation  of  low  levels  of  DNA  damage  in  individual  cells. 
Experimental Cell Research 175: 184–191.
Skalka  AM.  Katz  RA.  2005.  Retroviral  DNA integration  and  the  DNA 
damage response. Cell Death and Differentiation 12: 971–978.
Stern M, Gonzalez Cid M, Larripa I, Slavutsky I. 1994. AZT-induction of 
micronuclei in human lymphocyte subpopulations. Toxicology Letters 70: 
235–242.
75
Sun Y, Huang Y-C, Xu Q-Z, Wang H-P, Bai B, Sui J-L, Zhou P-K. 2006. 
HIV-1 Tat depresses DNA-PKCS  expression and DNA repair, and sensitises 
cells to ionising radiation. Int. J. Radiation Oncology Biol. Phys. 65: 842–
850. 
Thierens H, Vral A, De Ridder L. 1996. A cytogenetic study of radiological 
workers: effect of age, smoking and radiation burden on the micronucleus 
frequency. Mutation Research 360: 75–82.
Thierens  H,  Vral  A,  Barbe  M,  Aousalah  B,  De  Ridder  L.  1999.  A 
cytogenetic study of nuclear power plant workers using the micronucleus-
centromere assay. Mutation Research 445: 105–111.
Tubiana M, Dutreix J, Wambarsie A. 1990. Introduction to Radiobiology. 
London: Taylor and Francis.
Tucker  JD.  2008.  Low-dose  ionizing  radiation  and  chromosome 
translocations: A review of the major considerations for human biological 
dosimetry.  Mutation Research/ Reviews in Mutation Research,  659: 211–
220.
Varga D, Johannes T, Jainta S, Schuster S, Schwarz-Boeger U, Kiechle M, 
Patino Garcia B, Vogel W. 2004. An automated scoring procedure for the 
micronucleus test by image analysis. Mutagenesis 19: 391–397.
Vral A, Thierens H, De Ridder L. 1997. In vitro micronucleus-centromere 
assay  to  detect  radiation-damage  induced  by  low  doses  in  human 
lymphocytes. Int.J. Radiat. Biol. 71: 61–68.
76
Weier  HUG,  Lucas  JN,  Poggensee  M,  Segraves  R,  Pinkel  D,  Gray JW. 
1991. Two-color hybridisation with high complexity chromosome-specific 
probes  and a  degenerate  alpha  satellite  probe DNA allows unambiguous 
discrimination  between  symmetrical  and  asymmetrical  translocation. 
Chromosoma 100: 371–376.
Weng  H,  Morimoto  K.  2009.  Differential  responses  to  mutagens  among 
human lymphocyte subpopulations. Mutation Research 672: 1–9.
Wilkins RC, Wilkinson D, Maharaj HP, Bellier PV, Cybulski MB, McLean 
JRN.  2002.  Differential  apoptotic  response  to  ionising  radiation  in 
subpopulations of human white blood cells. Mutation Research 513: 27–36.
Willems P, August L, Slabbert J, Romm H, Oestreicher U, Thierens H, Vral 
A.  2010.  Automated micronucleus  (MN) scoring for  population triage in 
case  of  large  scale  radiation  events.  International  Journal  of  Radiation 
Biology 86: 2–11.
Wojcik A, Kowalska M, Bouzyk E, Buraczewska I, Kobialko G, Jarocewicz 
N, Szumiel  I.  2000. Validation of the micronucleus-centromere assay for 
biological dosimetry. Genetics and Molecular Biology 23: 1083–1085.
Wolff S. 1998. The Adaptive Response in Radiobiology: Evolving Insights 
and Implications. Environmental Health Perspectives 106: 277–283.
Wuttke K, Streffer C, Muller W-U. 1993. Radiation induced micronuclei in 
subpopulation of human lymphocytes. Mutation Research 286: 181–188.
77
Zielhuis  RL.  1984.  Recent  and  potential  advances  applicable  to  the 
protection  of  workers'  health  –  biological  monitoring.  II.  In:  Berlin  A, 
Yodaiken  RE,  Henman  BA (Eds.),  Assessment  of  toxic  agents  at  the 
workplace – roles in ambient and biological monitoring. Martinus Nijhoff 
Publishers, Boston.  
78
Appendix A
Product List
Cytogenetic tests:
Complete medium for method 1: 500 ml RPMI 1640 (Biowhittaker-
Lonza), 
75 ml Foetal Calf Serum, 
5 ml penicillin/streptomycin (Gibco).
Complete medium for method 2: 500 ml RPMI 1640, 
10 ml L-glutamine (Gibco), 
2.4 ml penicillin/streptomycin.
Phytohaemagglutinin (Invitrogen)
Cytochalasin B: 25 mg cytochalasin B (Sigma Aldrich)
3.3 ml DMSO (Sigma)
KCl (per 1l): 5.6 g KCl (Merck)
dH2O
Methanol (Merck)
Acetic acid (Merck)
Ringer (per 500ml): 4.5 g NaCl (AAR) 
0.21 g KCl (Merck) 
0.12 g CaCl2 
dH2O
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Slide Staining:
Acridine orange work solution: 0.4 ml stock 
40 ml dH2O 
Acridine orange stock solution: 0.1 g acridine orange stain
100 ml dH2O 
Acridine orange buffer: 1 tablet
1 l dH2O 
Vectashield with DAPI (Vector Labs)
FISH:
Ethanol (Merck) 70 %, 90 %, 100 %
Pretreatments:
RNase (100 µg/ml RNase) (per 1 ml):200 µl 500 µg/ml RNase (Roche) 
  800 µl 2 × SSC 
1 × PBS: 137 mM NaCl
2.7 mM KCl
10 mMNa2HPO4
1.76 mM KH2PO4
dH2O
pH = 7.4
Pepsin (3.5.1b): 0.5 µl of stock pepsin 
1 ml 10 mM HCl
Stock pepsin (1 mg/ml)(Sigma)
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HCl (10 mM) (10 ml) 1 ml 0.1 N HCl
9 ml dH2O
Pepsin solution (3.5.1c): 0.001 % pepsin
0.01 M HCl 
Postfixation buffer: 1 × PBS 
0.05 M MgCl2 
4 % paraformaldehyde: 4 % PFA 
1 × PBS, 
0.05 M MgCl2
1 N HCl (per 1 l): 31 ml 37 % hydrochloric acid (fuming) 
(Merck)
1 l dH2O
0.1 N HCl (per 1 l): 100 ml 1 N HCl
900 ml dH2O
Pepsin (3.5.1d): 25 mg pepsin (Sigma)
50 ml 01 N HCl
NB: The pepsin is only added when the 01 N HCl solution is at 37 °C, and 
the measurements need to be accurate.
1 % formaldehyde (per 500 ml) 13.5 ml 37 % formaldehyde
dH2O
pH = 7 (with NaOH)
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Hybridisation:
Denaturing solution (per 50 ml): 35 ml deionised formamide, 
5 ml phosphate buffer, 
5 ml 20 × SSC, 
5 ml  dH2O
pH = 7 (HCl)
STARFISH© denaturing solution: 70 % formamide (deionised)
2 × SSC
Deionised formamide (per 1 l): 1 l formamide (Merck)
10 heaped scoops of analytical grade  
mixed bed resin (Biorad)
Stirred for 2 hours, and filtered with Whatman filter paper  
Phosphate buffer (per 1 l): 413 ml solution A
587 ml solution B
pH = 7 (Solution A and B used to 
adjust pH)
Solution A (acid) (per 1 l): 9.08 g KH2PO4 (Saarchem)
dH2O 
Solution B (base) (per 1 l): 11.88 g Na2PO4.2H2O (Saarchem)
dH2O 
20×SSC (per 1 l): 175 g NaCl
88.23 g tri-sodium citrate
dH2O 
pH = 7 (HCl)
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STARFISH© commercial pan-centromeric probe (Cambio)
Washing:
2 × SSC (per 150 ml): 15 ml 20 × SSC
135 ml dH2O 
2 × SSC/0.1 % Tween: 50 ml 2 × SSC
50 µl Tween 20 (Merck)
50 % formamide (per 150 ml): 15 ml 20 × SSC
65 ml dH2O
70 ml formamide (Merck); not 
deionised 
DAPI stock solution (0.2 mg/ml): 10 mg DAPI (Merck)
50 ml 2 × SSC
DAPI work solution: 50 µl DAPI stock
50 ml 2 × SSC
Vectashield (Vector labs)
Rubber cement Fixogum (Marabu)
Bacterial culture:
Luria Broth medium (per 500 ml): 5 g tryptone (Merck) 
2.5 g yeast extract (Merck) 
5 g NaCl
dH2O
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Ampicillin 50 mg/ml: 0.5 g ampicillin
10 ml dH2O
Plasmid extraction:
Qiagen Plasmid Midi Kit
Buffer P1: 50 mM Tris-Cl (pH = 8), 
10 mM EDTA, 
100 µg/ml RNase A
Buffer P2: 200 mM NaOH, 
1 % SDS (w/v)
Buffer P3: 3 M potassium acetate (pH = 5.5)
Buffer QBT: 750 mM NaCl, 
50 mM MOPS (pH = 7), 
15 % isopropanol (v/v), 
0.15 % Triton® X-100 (v/v)
Buffer QC: 1 M NaCl, 
50 mM MOPS (pH = 7), 
15 % isopropanol (v/v)
Buffer QF: 1.25 M NaCl, 
50m M Tris-Cl (pH = 8.5), 
15 % isopropanol (v/v)
Isopropanol (BDH)
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TE Buffer (Promega): 10 mM Tris-Cl (pH = 8) , 
1 mM EDTA
DNA extraction:
Red blood cell lysis buffer (Roche)
Proteinase-K lysis buffer: 50 mM Tris-HCl, 
1 mM EDTA, 
0.5 % Tween, 
dH2O
pH = 8.8
Tris (1 M) (per 500 ml): 60.6 g Tris (Merck)
dH2O
pH = 8.5
EDTA (0.5 M) (per 1 l): 186.1 g disodium EDTA-2H 
(Boehringer-Mannheim)
dH2O
pH = 8
Proteinase-K (10 mg/ml): 10 mg proteinase-K (Roche)
1 ml dH2O
Prepared on the day of use.
Phenol (Sigma-aldrich)
Chloroform (Sigma-aldrich)
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PCR:
Forward primer (100 μM) (Operon biotechnologies):
50 nmol lyophilised primer
648 μl dH2O
Reverse primer (100 μM) (Operon biotechnologies):
50 nmol lyophilised primer
517 μl dH2O
10 × NH4 reaction buffer (Bioline) 160 nM (NH4)2SO4
670 mM Tris-HCl (pH = 8.8)
0.1 % stabiliser
MgCl2 (10 mM): 10 µl 50 mM MgCl2 (Bioline)
40 µl dH2O
BIOTAQ DNA polymerase (5 U/l) 
Storage buffer: 20 mM Tris-HCl (pH = 7.5)
100 mM NaCl
0.1 mM EDTA
2 mM DTT
50 % glycerol and stabilisers
dNTP mix (40 mM): 10 mM dATP
10 mM dCTP
10 mM dGTP
10 mM dTTP
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PCR purification:
High Pure PCR Product Purification Kit (Roche)
Binding Buffer: 3 M guanidine-thiocyanate, 
10 mM Tris-HCl, 
5 % ethanol (v/v), 
pH = 6.6
Wash Buffer: 20 mM NaCl, 
2 mM Tris-HCl, 
80 % ethanol, 
pH = 7.5
Elution Buffer: 10 mM Tris-HCl, 
pH = 8.5
BioSpin PCR amplicon purification kit (BioFlux)
Direct labelling:
Nick translation buffer: 0.5 M Tris
50 mM MgCl2
0.5 mg/ml BSA (Roche)
dH2O
MgCl2 (1 M) (per 100 ml): 20.331 g MgCl2 (Sigma-aldrich)
dH2O
β-mercaptoethanol (0.1 M) (per 15 ml): 0.1 ml β-mercaptoethanol 
(Sigma)
dH2O
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Table 5: Reagent volumes for dNTP mix
REAGENT VOLUME (µl) × 1
dATP (10 mM) (Promega) 1.5
dCTP (10 mM) (Promega) 1.5
dGTP (10 mM) (Promega) 1.5
dTTP (10 mM) (Promega) 0.75
Spectrum  Orange  dUTP  (1  mM) 
(Enzo)
7.5
dH2O 17.25
TOTAL 30
dNTPs (10 mM): 10 µl 100 mM dNTP stock
90 µl dH2O
Spectrum Orange dUTP (1 mM) (Enzo): 50 nmol lyophilised pellet
50 µl dH2O
Hybridisation buffer: 50 % deionised formamide, 
2 × SSC 
10 % dextran sulphate (Sigma), 
 50 mM sodium dihydrogen 
orthophosphate 
pH = 7
NaCl (0.3 M) (per 25 ml): 0.4383 g NaCl
dH2O
10 % SDS (per 100 ml): 10 g SDS (BDH)
dH2O
NaAc3 (3 M) (per 100 ml): 24.609 g NaAc3 (BDH)
dH2O
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DNase I stock solution: 3 mg DNase I (Roche)
0.5 ml 0.3 M NaCl
0.5 ml glycerol
DNase I work solution: 1 ml ice-cold dH2O
µl as required DNase I stock solution
Herring sperm DNA (10 mg/ml) (Promega)
Storage solution: 10 mM Tris-HCl (pH = 7.5)
10 mM NaCl
1 mM EDTA
Gel electrophoresis:
2 % agarose gels 0.8 g agarose (Bioline)
40 ml 1 × TAE buffer / 0.5 × TBE 
buffer
0.4 µl ethidium bromide
Instead  of  adding  the  ethidium  bromide  directly  to  the  gel  before 
electrophoresis,  the  gel  could  be immersed in  an ethidium bromide bath 
after electrophoresis for 30 minutes.
50 × TAE buffer (1 l) 242 g Tris
100 ml 0.5 M EDTA (pH = 8)
57.1 ml glacial acetic acid
dH2O
1 × TAE buffer (1 l) 20ml 50 × TAE buffer
dH2O
89
10 × TBE buffer (1 l) 108 g Tris
55 g boric acid
40 ml 0.5 M EDTA (pH = 8)
dH2O
0.5 × TBE buffer (1 l) 50 ml 10 × TBE buffer
dH2O
6 × orange loading dye (Fermentas)
O'Gene Ruler 100 bp ladder (Fermentas)
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Appendix B
A successful plasmid extraction is shown in Figure 16. The extracted DNA 
is electrophoresed on a 2 % agarose gel alongside λ DNA to determine if the 
extraction  was  successful,  and  to  determine  the  concentration  of  the 
extracted  DNA.  A spectrophotometer  could  not  be  used  as  the  genomic 
DNA would obstruct any reading. 
Figure 16: Extracted p82H DNA alongside lambda DNA
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The p82H plasmid was directly labelled by means of nick translation, and it 
was  deemed successful  by gel  electrophoresis  as  shown in Figure 17.  A 
DNA smear  between  200  bp  and  500  bp  should  be  visible,  as  well  as 
incorporation  of  Spectrum  Orange.  Unincorporated  Spectrum  Orange 
dUTPs can be seen below the smear.
Figure 17: Direct labelling of extracted p82H DNA
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PCRs were performed as stated in the methods, and were electrophoresed on 
a 2 % agarose gel (Figure 18). If two bands (at 175 bp and 345 bp) were 
visible, the reactions were regarded as successful (Weier et al, 1991). These 
PCRs were kept at 4 °C until they were purified with PCR purification kits 
(see Methods).
Figure 18: Successful PCR reactions (1–10) with two bands at 175 bp and 
345 bp
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Purified  PCRs  were  directly  labelled  by  means  of  nick  translation  (see 
Methods).  The  nick  translation  reaction  underwent  gel  electrophoresis 
Figure 19. Similarly with the direct labelling of p82H, the reaction was seen 
as successful if a smear was seen between 200 bp and 500 bp.
Figure 19: Direct labelling of purified PCR reaction 
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